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S U M M A R Y
Nephrotoxicity induced by non-steroidal anti-inflammatory drugs 
was investigated using the laboratory rat. Standard biochemical 
investigations, together with urinary enzyme examination, 
complemented the results of organ weight analysis and conventional 
pathological examinations.
Variations in kidney function caused by strain of rat, age, sex 
and spontaneous pathological change were encountered. These factors 
are important when assessing the degree of nephrotoxicity induced 
by large doses of analgesics.
The simple assessments performed on urine and blood samples and on 
the kidneys were adequate to detect necrotic change, but less 
severe changes were difficult to evaluate.
With aspirin it was difficult to induce kidney damage consistently, 
although susceptibility could be modified. Similarly, with 
phenylbutazone the kidney was not consistently found to be a common 
target organ. The nephrotoxic potential of indomethacin was 
difficult to define because of the ulcerogenic effects of this 
drug on the intestinal tract.
Analgesic nephropathy is more likely to be defined by epidemiological 
studies. Rodent data are of doubtful relevance in predicting 
nephrotoxicity in man.
Ci)
I N T R O D U C T I O N
Approximately five thousand medicinal drugs are in common use 
(Maugh, 1978) and many of these will reach the kidney. One of the 
main reasons that the kidney is a major potential target organ is 
its high blood supply - the kidney receives nearly 25 per cent of 
the cardiac output - but other physiological features, such as 
glomerular filtration and tubular reabsorption also make the kidney 
particularly susceptible to toxicants. The kidney has a high 
metabolic rate and is the site of formation of hormones that 
influence systemic metabolic functions (Schreiner, 197 2; Czerwinski 
and Pederson, 1975; Mitchell et al., 1977).
In laboratory animals used for toxicity studies, the incidence of 
nephrotoxicity is second only to that of hepatotoxicity (Heywood, 
1981); this is probably largely attributable to the high doses which 
are given and to the prolonged periods of administration. Renal 
toxicity, as an adverse sign, is less frequently seen in man 
(Fletcher, 1978).
A variety of compounds that can cause renal lesions have been 
identified (Table 1): these compounds range from mineral salts to 
antibiotics. The non-steroidal anti-inflammatory drugs have been 
shown to be particularly injurious to the kidney. These drugs are 
known to have adverse effects on several systems. The effects on 
the gastrointestinal tract are well defined, and are a direct result 
of those very mechanisms which bring about the therapeutic action. 
Gastric irritation is probably caused by the inhibition of prosta­
glandins by these drugs (Simon and Mills, 1980). The effects on 
platelet physiology are also recognised.
:1:
TABLE 1
Some suspected drug-induced renal diseases in man
Renal disease Suspected drugs References cited
Analgesic nephropathy Mixtures of
analgesics
Spuhler and Zollinger 
(1953)
Kincaid-Smith (1978)










Minetti et al. (1978) 
Kleinknecht et al. (1978) 
Lange (1978)





Wilfert et al. (1971)
Welles (1972)
McCurdy et al. (1968)
Tubular damage and 
crystalluria
Methoxyflurane Panner et al. (1970) 





Winterborn and Mann (1973) 
Glushien and Fisher (195Q 
Mudge (1971a and b)
Duggan and Rohner (1973)
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TABLE 1 (continued)
Some suspected drug-induced renal diseases in man
Renal disease Suspected drugs References cited
Osmotic nephrosis Dextran Fournier et al. (1969)
Retroperitoneal
fibrosis
Methysergide Graham et al. (1966)
Diabetes insipidus Lithium salts Singer and Rotenberg 
C1973)
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The wide clinical indications for analgesics and anti-inflammatory 
drugs, particularly in the treatment of rheumatic diseases have 
encouraged the marketing of numerous compounds: some of those 
commonly available are listed in Table 2. Several of the analgesics 
that have been associated with nephropathy are freely available, 
over-the-counter preparations [Table 3). Most currently available 
compounds, apart from the salicylates, have been subject to the 
statutory animal toxicity test, including carcinogenicity studies.
In 1953 Spuhler and Zollinger drew attention to the association 
between the heavy consumption of analgesic mixtures and 
chronic interstitial nephritis in women in Switzerland. Renal 
papillary necrosis appeared to be a prominent feature of 
this syndrome. Over the decade many publications confirmed 
the findings in Switzerland, and the syndrome was shown to- 
be present in much of the developed world, such as North America, 
Scandinavia, Europe, Australia and South Africa (Kerr and Ward, 1977; 
Carro-Ciampi, 1978). The mechanisms of analgesic nephropathy were 
controversial. It was not clear whether the analgesics themselves 
were nephrotoxic, or merely caused predisposition to urinary tract 
infection. The nephrotoxic components of the analgesic mixtures 
were not known. The primary kidney lesions were undefined and the 
debate focused on whether a papillary necrosis or an interstitial 
nephritis was involved. The importance of the sociological impli­
cations were generally realised, but it was not known why analgesics 
were abused, nor how abuse should be defined.
Phenacetin was identified as the prime suspect. The free sale of 
phenacetin was restricted in Scandinavia in 1961, and subsequently 
there was a decline in the rate of deaths from analgesic nephropathy 
(Kjaerulff and Harvald, 1968; Nbrdenfelt, 1972), The withdrawal of
: 4 :
TABLE 2











Aspirin is the most commonly used 
drug for chronic arthritic diseases 






Phenylbutazone is a very effective 




These compounds have replaced 
phenylbutazone for acute musculo­
skeletal conditions.
ARYLINDOLES 
Fendosal These compounds are chemically related 
to indomethacin but less potent.
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TABLE 2 (continued)





They structurally resemble indometh­
acin, with action and toxicity 











Less irritant to gastro-intestinal 






Are no better than aspirin for 




Dermatitis is a problem.
No dermatitis;, similar to indometha­




Types of non-steroidal anti-inflammatory drugs
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phenacetin from Vincent's powders in Australia did not alter the 
clinical features or course of analgesic nephropathy over the period 
1967-1976 (Kincaid-Smith, 1978). Burry et al. (1974) in Australia, 
indicated that, although the death rate attributable to analgesic 
nephropathy declined following the withdrawal of phenacetin, renal 
damage persisted.
Aspirin, the most commonly used anti-inflammatory drug, was suspected 
next. Salicylates are relatively more potent nephrotoxins in 
laboratory animals than are phenacetin or paracetamol (Nanra et al., 
1971; Molland, 1978), and it is well known that they cause a 
transient decrease in renal function in man (Kimberly and Plotz,
1977; Kimberly et al., 1978). When salicylates are given under 
medical supervision, they do not appear to be very nephrotoxic to 
man (Caughey et al,, 1974; Nanra and Kincaid-Smith, 1975). In a 
clinical study on rheumatism, Ferguson et al. (1977) showed that 
consumption of large quantities of aspirin alone was not associated 
with renal papillary necrosis, although aspirin in association 
with phenacetin did have this adverse effect.
Analgesic nephropathy appears to be associated with mixtures of 
analgesics taken over long periods, and in an uncontrolled manner.
Rosner (1976) points out that there is no good toxicological 
definition of analgesic abuse. The word abuse implies that the 
compound is taken without medical justification. It is not possible 
to define abuse in terms of compound intake, although several people 
have made an attempt to define what they consider constitutes abuse 
in terms of phenacetin intake (Gault et al., 1968b; Bell et al.,
1969; Murray et al., 1971; Burry, 1973).
:10:
The sociological implications of analgesic abuse are now 
appreciated and there are several possible causes. The syndrome is 
found mainly in women aged 40-50 years (Kasanen et al., 1962). Older 
patients with headaches or arthritic pains are another group at 
risk (Gault et al., 1968a). Psychological and emotional disturbances 
are important, and signs of drug-dependence have been recognised in 
some patients (Gault and Wilson, 1978; Murray, 1978; Stewart, 1978). 
For the past 30 years analgesic nephropathy has been recognised as 
a definite clinical entity: a voluminous literature documents the 
syndrome (Kerr and Ward, 1977). A recent editorial in the New 
England Journal of Medicine (Goldberg and Murray, 1978) and the 
ensuing correspondence, suggest that this is still a major problem.
A. The pathology of analgesic abuse in man
Papillary necrosis has been classified into two types (Schourup, 
1957). Type one necrosis is usually acute, with an acute inflamma­
tory infiltrate, and is commonly associated with diabetes mellitus 
or urinary tract obstruction, with or without infection. The 
polymorphonuclear leucocytes form a demarcation zone at the base of 
the papillae. Haemodynamic factors are important in the development 
of this type of necrosis (Burry, 1971).
Type two necrosis evolves slowly and is associated with the abuse of 
analgesics. There is papillary necrosis, but no leucocyte 
infiltration. Unlike pyelonephritis, calyceal deformities are not 
a prominent feature and in advanced stages of analgesic-induced 
renal failure, shrunken irregular kidneys weighing less than normal 
are seen.
:11:
Burry (1967) recognised three stages of type two necrosis: early, 
intermediate or total necrosis. From the accounts of Kincaid-Smith 
(1967), Burry (1967; 1978) and Gloor (1978), it is possible to 
define early, intermediate and total papillary necrosis. While it 
is generally agreed that the lesion is progressive and that chronic 
interstitial nephritis is secondary to total papillary necrosis, 
pathologists disagree about the site of the earliest changes and 
the mechanisms of cortical change.
In early renal papillary necrosis the kidneys are macroscopically 
within the normal limits and their weights are within the normal 
range. On sectioning, the papillae have a bluish or greyish 
discolouration at the tip, which may extend in streaks for some 
distance up the papillae. The outer medulla is not involved. 
Microscopic examination shows patchy lesions. There is some 
difference of opinion as to where the first changes are seen.
Gloor (1978) stated that the first changes seen occurred in the 
ground substance and basement membrane of the loops of Henle and 
capillaries. These areas were shown to stain heavilv with PAS and 
Sudan. Electron microscopy showed marked lamellar concentric thick­
ening of the loops of Henle. The lumen was narrowed but the 
epithelial cells were preserved. In later stages, epithelial cells 
of the inner medulla lost their podocytes, and autophagic vacuoles 
appeared in the cytoplasm. The collecting ducts were unaffected.
Burry (1978) recognised necrosis of interstitial cells, loops of 
Henle and capillaries, with increased PAS staining and fat 
deposition. Deposits of calcium salts were also found. Both Gloor 
and Burry are in general agreement that the basement membrane of 
the collecting ducts is not affected and only the inner medulla is 
involved.
:12:
In contrast, Kincaid-Smith (1967) recognised the first microscopic 
changes in the tubules and interstitium of the outer medulla. At 
this site the epithelium of the tubules showed irregularities and 
patchy dilatation. Amorphous crystalline material was present 
within the tubules and the interstitium, where a cellular response 
started and an increase in interstitial tissue, with or without 
granulomata, was seen. Patchy necrosis of the loops of Henle was in 
evidence, but the adjacent blood vessels and collecting ducts 
appeared normal.
Intermediate papillary necrosis presents changes similar to those 
seen in earlier lesions, but the lesion is more widespread. The 
kidneys appear to be normal in shape and weight. Changes in the 
cortex are not apparent. On cross-section, yellow or greyish areas 
are seen, extending to the junction of the inner and outer medulla 
and the papilla may be shrunken with a brownish discolouration. 
Microscopic examination shows that all elements are necrotic, apart 
from collecting ducts and the occasional vasa recta. PAS-positive 
material, fat, and often calcified material are present. The 
pattern of changes towards the outer medulla rcj-mbles the earliest 
changes encountered first at the tip of the papilla. The collecting 
duct and vascular bundles survive, whereas the loops of Henle and 
interstitium do not. Gloor (1978) recorded, in addition, an increase 
in fibroblasts, monocytes, and lymphocytes in the outer medulla, and 
an increase in collagen fibres around the medullary blood vessel.
With long-standing total papillary necrosis, the kidneys are grossly 
shrunken, fibrotic, and weigh less than normal. In cases where the 
papilla has only recently become necrotic, the cortex may appear 
normal. On cross-section, necrosis appears in the form of either a 
cap or crescent at the tip of the papilla, often with cavitation.
:13:
In other cases, the necrotic papilla may be partly or completely 
detached, and may either sit in a dilated calyx or enter the ureter 
to be voided or obstruct the lumen. In some cases the papillae have 
a striking brown discolouration, which Nanra et al. (1978) attributed
to a breakdown product of phenacetin. On histological examination, 
all elements of affected papillae are seen to be necrotic. The 
fornical margins appear to be less affected, and collecting ducts 
may survive. If central necrosis with cavitation occurs, this area 
undergoes epithelialisation from the epithelium of collecting 
ducts at the cortical margin. Fibrosis and sclerosis are prominent 
features in the medulla above the necrotic papilla. The fibrosis 
is most marked when the necrotic papilla remains iu situ. If a 
papilla is shed, a fibrotic epithelialised stump is seen, occasion­
ally penetrated by surviving collecting ducts. In some instances, 
where necrotic epithelial cells of collecting ducts are shed, 
fibrous tissue formed at these sites is said to provide a nidus for 
bone formation. The fibrotic papillary remnants subsequently become 
severely shrunken. The cortical changes are variable. Initially, 
oedematous interstitial tissue with scant round-cell infiltration 
separates atrophic tubules. Glomeruli are spared at this stage, but 
appear to be closer together because of tubular atrophy. The most 
marked cortical changes occur adjacent to areas of medullary 
fibrosis and sclerosis resulting from a necrotic papilla ^  situ.
In these sites the cortex finally shows interstitial fibrosis and 
inflammatory-cell infiltration with approximation and hyalinisation 
of glomeruli.
Obliterative arterial changes characterised by intimai thickening 
may also be seen at this time within the arcuate and intralobular 
arteries. The areas of cortex not overlying the necrotic papillae 
(columns of Bertin) may survive and appear hypertrophic. The
: 14 :
development of these cortical changes is a controversial issue.
Burry (1967) and Kincaid-Smith (1967) have found collecting ducts 
surviving in the fornical region and believe that this may explain 
the survival of the columns of Bertin.
Murry et al. (1972) are of the opinion that the cortical changes are 
secondary to the loss of loops of Henle. Microangiopathy has been 
recognised in patients presenting with analgesic nephropathy.
Abrahams (1976), Abrahams et al. (1976), Gloor (1978) and Mihatsch 
et al. (1979) recognised amorphous thickening of the walls of 
capillaries, arterioles and venules in the subepithelial connective 
tissue of the renal pelvis, ureter and bladder in some patients with 
total analgesic nephropathy. It was postulated that these changes 
in subepithelial blood vessels, which are important in supplying 
blood to the papilla in man, may explain the pathogenesis of the 
papillary necrosis as being attributable to slow infarction of the 
medullary structure.
An association between analgesic abuse and kidney tumours has also 
been noted. In Sweden, Hultengren et al. (1965) and Bengtsson et 
al. (1968) noted an association between the abuse of phenacetin- 
containing drugs and renal papillary necrosis and urothelial 
tumours of the kidney, and this has been confirmed in a further 
report from Sweden by Johansson et al. (1974). It is thought that 
phenacetin or a metabolite is carcinogenic; the degenerative and 
inflammatory lesions are not pre-cancerous.
A variety of adverse reactions, other than renal, associated with 
the use of non-steroidal anti-inflammatory agents have been recorded. 
These are listed in Table 4.
:15:
TABLE 4
Non-renal toxicity associated with non-steroidal anti-inflammatory
drugs in man.
Organ system and toxicity Drug
b o n e m a r r o w
Hypoplastic or aplastic 











Haemorrhagic anaemia Aspirin Linton (1972)
Haemolytic anaemia Aspirin, phenacetin Beutler (1969) 
Amidopyrine, Mefenapic Horler (1977) 
Acid, Flufenamic Acid Linton (1972)
Inhibition of platelet Aspirin, Indomethacin, O'Brien et aL (1970)
aggregating factor Ibuprofen. Horler (1977)
Increased plasma fibrinogen Aspirin Woodbury arid
Fingl (1975)
Neonatal hyperbilirubin Aspirin, Indomethacin Gadeke (1972)
-aemia




Non-renal toxicity associated with non-steroidal anti-inflammatory
drugs in man
Organ system and toxicity Drug




Aspirin, Indomethacin Brewis (1977)
Mefenamic acid Vaneslow and 
Smith (1967) 
Smith (1971)





with systemic lupus 
erythematosus)
Phenylbutazone Brewis (1977)
Pulmonary oedema Phenylbutazone Nevins et al. 
(1969)
CARDIOVASCULAR SYSTEM
Salt and water retention/ Phenylbutazone 
Hypertension Oxyphenbutazone
Cardiac Ischaemia Indomethacin




Polyarteritis nodosa Phenylbutazone Felix and 
Stevenson (1977)
:17:
TABLE 4 (continued 3)
Non-renal toxicity .associated with non-steroidal anti-inf lammatory
drugs in man.
Organ system and toxicity Drug References cited
ALIMENTARY SYSTEM 
Gastric haemorrhage Aspirin Alvarez and 
Summerskill (1958) 











Phenylbutazone Davies and 
Brightmore (1970)
Parotitis Oxyphenbutazone Gross (1969)





Fenech et al. 
(1967)
Engleman et al. 
(1954)
Goldstein (1963)
Hepatic necrosis Aspirin Seaman et al. 
(1974)
:18:
TABLE 4 (continued 4)
Non-renal toxicity associated with nonrsteroidal anti-inflammatory
drugs in man.
Organ system and toxicity Drug References cited


















Anderson et al. 
(1962)




Aspirin McClelland X1977) 





Indomethacin Hart and Boardman 
(1965)
19:
TABLE 4 (continued 5)
Non-renal toxicity associated with non-steroidal anti-inflammatory
drugs in man. " ~ ~








Co H u m  and Bowen 
(1971)
Retinal damage Indomethacin Burns (1968)




Corneal opacity Indomethacin Burns (1968)
Mydriasis Indomethacin, Aspirin Crombie (1977)
Cortical blindness Salicylates Crombie (1977)
REPRODUCTIVE SYSTEM 
Teratogenicity Aspirin Nelson and Forfar 
(1971)
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TABLE 4 (continued 6)
Non-renal toxicity associated with non-steroidal anti-inflammatory
drugs in man.
Organ system and toxicity Drug References cited
METABOLIC CHANGES
Hyperuricaemia and gout Aspirin,
Phenylbutazone
Bluestone et al. 
(1969)
Hyperglycaemia Salicylates Anderson (1977)
ENDOCRINE CHANGES 
Inhibition of thyroid 
hormone biosynthesis
Phenylbutazone Evered and 
Turnbridge (1977)
ALLERGIC REACTIONS 















B. Experimental renal pathology induced by analgesics
The experimental pathology has been reviewed by Shelley (1967), Abel 
(1971), Nanra and Kincaid-Smith (1972), Michielsen et al. (1972), 
Rosner (197 6 ) and Holland (1978) .,
As phenacetin had been implicated as a potentially nephrotoxic 
compound, it has been the subject of much experimental work.
Most attempts to produce renal lesions with phenacetin or its 
metabolite, paracetamol, have failed. The initial idea of Meisher 
et al. (1958), that phenacetin made the kidney more susceptible to 
infection, was refuted by the work of Dawborn et al. (1964) and 
Vivaldi (1968) . Massive doses of phenacetin given to rats (Fordham 
et al., 1965) produced minor papillary necrosis and some epithelial 
alterations in both the medulla and cortex. The changes comprised 
vacuolation of epithelial cells, with an increase in the number of 
mitotic figures, and pigment within the cytoplasm of epithelial 
cells. Clausen (1965), working with rabbits, induced kidney lesions 
after massive phenacetin overdosage: and in this case the lesion was 
that of tubular dilatation and calcification with fibrosis.
Dehydrated female Sprague-Dawley and Wistar rats, given 3000 mg/kg/ 
day of phenacetin or paracetamol for 8 - 2 0 weeks, showed mild necrotic 
papillary changes (Nanra et al., 1971). Axelsen (1976) working 
with the homozygous Gunn rat given a single dose of phenacetin, also 
found mild necrotic papillary changes. Holland (1978) administered 
phenacetin in 5% alcohol in the drinking water at a dosage level of 
137 mg/kg/day or paracetamol at a dosage level of 894.2 mg/kg/day, 
and produced in the Lister Hooded rat an intermediate papillary 
necrosis (as defined by Burry, 1967) after 36-54 weeks.
Although severe renal damage has been produced in laboratory rats 
with aspirin, it has proven difficult to induce renal papillary 
necrosis without making physiological modification. Renal tubular
:22:
dilatation, fibrosis and calcification were induced in rabbits given 
500 g of aspirin over a 12-month period (Clausen, 1965) . Lister 
Hooded rats which received approximately 285 mg/kg/day of aspirin in 
their drinking water developed an intermediate-type papillary 
necrosis by 36 weeks (Holland, 1976) , whereas at a dose level of 318 
mg/kg/day, aspirin produced total papillary necrosis and cortical 
changes within 18-24 weeks (Holland, 1978). The initial change 
affected the interstitial cells of the papilla; later changes 
included fibrosis, deposits of amorphous material within the vessels 
and surrounding tissue, and mild inflammatory responses within the 
vascular bundles of the outer medulla. Segmental necrosis of the 
proximal convoluted tubules of female Lister Hooded rats has been 
described by Calder et al. (1971) and in male and female Wistar rats 
by Arnold et al. (1973a and b). These lesions were induced by 
administering a single dose of aspirin.
The production of renal papillary necrosis by aspirin has been 
facilitated by dehydrating rats for 16-18 hours a day and addition­
ally by inducing oligaemic shock by withdrawal of 2-3 ml of blood 
by cardiac puncture (Nanra and Kincaid-Smith, 1970; Nanra, 1974). 
Lister Hooded rats, subjected to unilateral nephrectomy and given 
285 mg/kg/day of aspirin, developed total papillary necrosis (Holland, 
1976). In 1978, Holland used the technique of partial papillectomy ' 
to demonstrate that rats could develop chronic interstitial nephritis 
in the absence of papillary change, when given aspirin. Using the 
Gunn homozygous rat, Axelson and Burry (1972) showed that this strain 
was susceptible to renal papillary necrosis when given aspirin at a 
level of 500 mg/kg/day for up to 23 days; his aspirin-treated Wistar 
strain rats did not develop papillary l e s i o n s I n  later experiments, 
Axelson (1976) demonstrated that a single dose of aspirin induced 
more necrotic papillary damage than phenacetin in the Gunn rat.
:23:
Aspirin, in combination with phenacetin and caffeine, produced 
renal papillary necrosis when given to rats (Abrahams and Levin,
1967; Saker and KinCaid-Smith, 1969; Nanra and Kincaid-Smith, 1970, 
Nanra et al., 1971; Phillips et al., 1976). In these experiments 
it was shown that the aspirin lesion was more marked if it was 
given in combination with other compounds. In an experiment 
designed to ensure that animals received the salicylate levels found 
in human analgesic users, renal lesions were not induced in rats 
given aspirin alone, but were induced in rats given aspirin in 
combination with phenacetin and caffeine (Philips et al., 1976).
Renal papillary necrosis has been produced by a variety of other 
non-steroidal anti-inflammatory agents in rats, Arnold et al. (1974; 
1976) induced, in female Wistar rats, renal papillary necrosis 
following single doses of phenylbutazone of 50-400 mg/kg and 
indomethacin at dose levels of 50-75 mg/kg. Phenylbutazone (10 mg/ 
kg/day) and indomethacin (12 mg/kg/day), mefenamic acid (100 mg/kg/ 
day) phenazone (1 000 mg/kg/day) and propoxyphene (100 mg/kg/day) 
when given to female Sprague-Dawley and Wistar rats which were 
subjected to 16-18 hours dehydration daily, produced necrotic 
papillary changes in a proportion of the rats after 8-30 weeks of 
drug administration (Nanra and Kincaid-Smith, 1973). Of the drugs 
investigated, mefenamic acid was the most nephrotoxic. Amidopyrine 
(1200 mg/kg/day) (Brown and Hardy, 1968) and flufenamic acid (50-100 
mg/kg/day) (Hardy, 1968) produced substantial necrosis of the renal 
papilla in male Sprague-Dawley rats. Lesions were not induced with 
phenazone at a dose of 1300 mg/kg/day. Ibuprofen did not induce 
renal papillary necrosis in rats (Adams et al., 1969). An indene 
analogue of indomethacin produced mild renal papillary necrosis in 
Sprague-Dawley rats, focal urothelial hyperplasia, haematuria, but 
no necrotic papillary changes in Manor Farm SPF rats (Bokelman et al., 
1971). Fenoprofen is recorded by Emmerson et al. (1973) as
: 24 :
producing renal papillary necrosis in rats. Sudoxicam gave rise to 
a sex-related renal papillary necrosis involving only female rats 
(Wiseman and Reinert, 1975). Acemetacin has been recorded as 
inducing renal papillary necrosis (Jacobi and Dell, 1980).
C. Toxicological aspects of the effects of analgesics on the rat 
kidney
Despite the wide interest in the syndrome of analgesic nephropathy 
and the recognition of a causal relationship with mixtures of 
analgesics, the precise pathogenesis and the aetiological agent or 
agents involved are still unknown (Gloor, 1978; Shelley, 1978).
Current philosophy of toxicology is to define target organ systems 
and make an assessment of safety margins, by using rodent and non­
rodent species in carefully controlled short- and long-term toxicity 
studies. Rosner (1976) reviewed the data obtained from animal 
studies with analgesics and concluded that, if the pathologists and 
clinicians had not drawn attention to the problems of nephropathies 
induced by analgesic abuse in man, the toxicologist would never have 
suspected, foreseen or predicted the existence of such a syndrome. 
With the new non-steroidal anti-inflammatory drugs the kidney is 
frequently recognised as the major target organ. Long-term studies 
are sometimes carried out at dose levels below that used in man, in 
order to obtain a no-effect level in the rat. We must consider 
whether the rat is a suitable experimental model for analgesic 
nephropathy. It is the aim of this thesis to examine some factors 
which may affect the susceptibility of the rat to renal lesions 
induced by analgesics.
: 25 :
P A R T O N E
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1. The assessment of renal toxicity in the laboratory rat
The white rat is the common laboratory mammalian species used in 
toxicological studies, usually the outbred Sprague-Dawley and 
Wistar strains. Several inbred strains of rat have been developed, 
some of which have properties that might be of value in the 
investigation of nephrotoxicity. The SHR is such a strain, being 
prone to hypertension with no obvious primary organic lesions in the 
kidneys or adrenal gland. The availability, convenient size and 
physiology of the common laboratory rat facilitates experiments 
designed to assess nephrotoxicity. It is necessary to know the 
range of normal and spontaneous pathological variations common to 
the test species. In the rat many spontaneous abnormalities occur 
congenitally or as a result of infection or developmental and aging 
processes.
The test procedures used by the research worker are essentially the 
same as those applied in general clinical practice. Water intake 
can be measured and the urine volume collected for analysis. In 
addition, blood samples can be taken for cytological and chemical 
investigation.
Rats in our toxicological studies are barrier-maintained, and housed in 
groups of five in suspended metal cages with wire-mesh floors. Room 
temperature and humidity are maintained at 21°C - 2°C and 50% - 5%, 
respectively. Lighting is controlled to give 12 hours light (08.00 
- 20.00 h) and 12 hours dark per day. They are fed on Spillers 
Laboratory Small Animal Diet or Spratts Laboratory Rodent Diet No. 1 
or No. 2, and tap water is freely available.
:27:
1.1 Water intake
Water consumption is measured at intervals during the course of a 
toxicological study, over a minimum period of five consecutive days. 
The water consumed over 24-hour periods is weighed.
The water consumption of male and female Sprague-Dawley rats, 
together with the changes with age, are presented in Table 5. Young 
adolescent male rats tend to consume slightly more water than 
sexually mature male animals. Subsequently, water consumption tends 
to increase with age. In females, water consumption over the first 
year of age is remarkably constant. As with the males, water 
consumption tends to increase with age. Aged male and female animals 
consume the same amount of water daily.
1.2 Collection and examination of urine
Urine samples are collected from rats, housed in metabolism cages, 
fitted with separators which allow for the collection of urine with­
out faecal contamination. The procedure for collecting 16-18 hour 
urine samples from animals without access to food and water, is to 
house the rats separately in these cages. The procedure for taking 
urine concentration test samples is to deprive the rats of water for 6 
hours, and before introducing them into the metabolism cages to 
express manually any urine in their bladder. The rats are left in 
the metabolism cages for 2 hours, but as each rat is removed, any 
urine remaining in the bladder is expressed into the separator for 
collection. Insufficient data were available to show the results 
of the urinary concentration test in our rats. The results of 




Age of rats MALES FEMALES
(weeks) Mean - SD Range Mean - SD Range
17 43 - 7 30 - 55 3 0 - 4  25 - 39
Cn=1 0 0 )
30 35 - 4 30 - 44 30 - 3 25 - 37
(n=1 0 0 )
56 33 - 6 27 - 49 30 - 3 24 - 38
(n=1 0 0 )
82 38 - 7 25 - 51 37 - 9 22 - 52
(n=1 0 0 )
108 49 - 14 30 - 73 49 - 14 33 - 87
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Semi-quantitative evaluations of urine samples in male and female 
rats
Abbreviations; E = Epithelial cells
P = Polymorphonuclear 
leucocytes
M = Mononuclear leucocytes
R = Red blood cells
0 = Organisms 
C = Casts
A = Abnormal constituents 




Male rats tend to excrete a greater volume of urine than female 
animals. There is an increase in urinary volume in both sexes with 
age, but the difference between male and female is less marked from 
82 weeks of age.
The volume of urine voided depends on the degree of hydration, 
glomerular filtration and tubular function. The secretion of 
vasopressin from the posterior pituitary is an important homeo­
static mechanism. The urinary tract must be unobstructed. Renal 
diuresis has previously been reported in aging male Sprague-Dawley 
rats by Foley et al. (1964); this study showed that diuresis also 
occurs in the female animals. This diuresis does not appear to be 
related to endocrine dysfunction.
1.2.2 Specific gravity
The specific gravity of the urine decreases with age, the effect 
being similar in male and female animals. The*variation in specific 
gravity appears to be inversely proportional to the increase in the 
urinary volume. By measuring the volume and specific gravity of the 
urine voided overnight when water has been witheld, a crude kidney 
concentration test has been performed. The data indicate that, with 
age, the kidney is less capable of concentrating the urine.
1.2.3 Urinary pH
Female rats tend to have a more acidic urine than male rats. 
Although little significant change takes place in the urinary pH
:35;
values with age, there is a tendency in the middle-age group, that is 
animals between 30 and 82 weeks of age, for the urine to become 
neutral.
1.2.4 Urinary protein
A progressive increase in protein loss in the urine is the most 
significant age-related change. This effect is particularly marked 
in the male animals. Proteinuria in albino rats is well documented 
(Gray, 1977). Specific sex-related low molecular weight proteins, 
possibly globulins, synthesised in the liver and excreted by the 
kidney, appear in the urine of male rats between six and ten weeks of 
age (Alt et al., 1980a). As the rats age, the proteinuria associated 
with increased glomerular permeability, attributable to chronic 
progressive nephropathy, is seen in both sexes, but mainly in the 
males. Albumin becomes more abundant and the albumin/globulin ratio 
alters (Berg, 1965; Weaver et al., 1975; Gray, 1977). In older rats, 
the urinary proteins resemble serum proteins (Bolton et al., 1976) 
and the low molecular weight proteins are virtually absent in male 
animals (Alt et al., 1980a). Alt and her colleagues (1980b) 
recommended that selective determination of albumin in urine by 
electrophoretic separation of urinary proteins, was indispensible for 
the estimation of renal permeability.
1.2.5 Urinary total reducing substances
Tbtal reducing substances are found in the urine of a small 
proportion of rats at all age groups, but particularly in those 
around the 56 to 8 2-week age group.
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1.2.6 Urinary glucose
Urinary glucose is rarely found, but when it does occur it is 
usually in rats over 56 weeks of age.
1.2.7 Urinary ketones, bile pigments and urobilinogen
These tests are indicative of disturbances in the metabolism of the 
liver and are best considered as liver function tests rather than 
tests of nephrotoxicity.
1.2.8 Urinary blood pigments
The presence of blood pigments in the urine can be due to pre-renal, 
renal or post-renal damage, and is most noticeable in male animals, 
particularly those aged 8 2 weeks or more. This finding of blood 
pigments can be correlated with the increased incidence of chronic 
progressive nephropathy in the Sprague-Dawley rat.
1.2.9 Microscopy of spun deposits
Epithelial cells are present in the urine of male and female rats at 
all ages. Polymorphs occur in a proportion of rats from all age 
groups. The red blood cells, however, appear more commonly in male 
than in female rats and are certainly greater with age. Mononuclear 
cells, organisms, casts and abnormal constituents are found in urine 
samples but they show little change with age.
:37:
1.3 The collection and analysis of blood samples
Blood samples are taken from rodents that have been fasted overnight. 
There are three techniques for bleeding rodents: tail bleeding, 
heart puncture, or bleeding from the orbital sinus. Of these 
techniques that of orbital sinus bleeding is preferred. Samples 
are obtained from lightly anaesthetised rats by inserting an orbital 
pipette into the orbital sinus - ophthalmic venous plexus. Samples 
of 2 ml are usually withdrawn.
1.3.1 Plasma urea
Only the plasma urea value is measured as an indicator of kidney 
function in toxicological studies. Age changes in plasma urea 
values are presented in Table 9. These values remain remarkably 
constant, and increase only in very old male animals. The 
expansion of the range of values in old male rats is related to the 




Plasma urea (mg %) for male and female rats
AGE OF RATS MALE FEMALE
(weeks) Mean S. D . Range Mean S.D. Range
17 32.5 - 5.4 22 - 52 36.9 - 7.6 23 - 57
(n=1 0 0 )
30 32.3 i 5.4 22 - 49 38.7 - 7.8 24 - 73
(n=1 0 0 )
56 30.5 - 8.7 18 - 82 33.0 i 7.5 19 - 54
(n=1 0 0 )
82 29.7 - 9.7 16 - 101 30.6 - 7.2 17 - 48
(n=1 0 0 )
108 41.8 - 37.6 18 - 280 30.3 ~ 12.2 17 ^ 124
(n=1 0 0 )
:39:
1.4 Pathological assessment
The pathological assessment of toxic effect in animals is usually 
based on organ weight analysis and description of the macroscopic 
and microscopic appearance of the tissues. Emphasis is on 
comparison of data from test and concurrent control animals, 
although knowledge of the spontaneous and age-related variations 
in the weight and structure of organs is necessary.
1.4.1 Organ weights
Analysis of organ weights is fundamental to many biological studies 
and is of particular importance in toxicological studies. It is 
accepted practice to present these weights as absolute organ 
weights or as relative organ weights, that is as a percentage of 
body weight. Trieb et al. (1976) established, for the kidney, a 
significant linear, positive correlation, between organ and body 
weight. In rodents with impaired body weight gain the relationship 
between kidney and body weight remains constant (Schwarz et al., 
1973; Scharer, 1977). Changes in body weight and kidney weight, 
relative to age, are presented in Tables 10 and 11. Male rats show 
a slight body weight loss after 82 weeks of age, and both the 
absolute and relative kidney weights are increased. The slight 
weight loss in old male rats is caused by many factors, although 
undoubtedly the severe renal damage must make some significant 
contribution. In these old male rats the kidney weight increase is 
consistent with the finding of chronic progressive nephropathy. 
Hypertrophy of nephrons (Gray, 1977) and/or hyperplastic epithelial 
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The smooth, reddish-browiv bean-shaped kidneys, lie in a retroperito­
neal position and dorsal in the abdominal cavity (Fig, 2). The right
kidney and adrenal gland occupy a more cranial position than the left. 
On sectioning there is a single slender papilla (Fig J). Four zones can
be identified: the cortical, the subcortical, the outer medullary and
the inner medullary zone (Fourman and Moffat, 1964; Snell, 1967;
Hebei and Stromberg, 1976). Although the kidney has a single 
papilla, the renal pelvis is extensively folded, and this folding is 
characteristic of those mammals with a high urinary concentrating 
capacity (Lacy, 1980). The blood supply to the kidneys is via 
the r e n ^  arteries, which divide at the hilus into six to ten 
interlobar arteries branching to the walls of the renal pelvis, 
ureter, renal capsule and brown fat in the hilar region. These 
arteries then form a number of arcuate arteries at the corticomedul- 
lary junction. Arcuate arteries may give rise to a few afferent 
arterioles supplying juxtamedullary glomeruli, but the majority form 
interlobular arteries which run parallel to each other and perpen­
dicular to the surface of the kidney, and give rise to most of the 
afferent arterioles which supply the glomeruli. Glomerular efferent 
arterioles are of two types. Cortical glomerular efferent arterioles 
break up into capillary plexuses which supply the cortical zone of 
the kidney. One or two efferent arterioles from each juxtamedullary 
glomeruli may supply the capillary plexuses of the subcortical zone, 
or form vasa recta which run together as vascular bundles in the outer 
medulla and descend to supply the inner medulla. Vessels branch off 
from the vascular bundles to supply capillary plexuses at all levels 
of the subcortical zone and medulla, and some descend as single 
vessels to supply the tip of the papilla. Each efferent arteriole 
may form up to thirty vasa recta which have the same diameter as the 
parent trunk. This vascular pattern may explain the slow blood flow 
and low blood pressure in the medulla (Fourman and Moffat, 1964) .
: 43 :
Fig. 2. The ventral surfaces of the kidneys are seen 
surrounded by retroperitoneal adipose tissue and lying 
on either side of the colon. The anterior pole 




Fig. 3. Transverse section of a normal kidney. The four 
zones referred to in the text can be identified.
; 45 :
The blood supply to the single papilla is from the vasa recta 
(Moffat and Fourman, 1963).
The venous-'drainage of the cortex is by cortical capillaries 
draining into interlobular veins and then to arcuate veins.
The subcortical zone and the medulla are drained by wide venous 
channels, some of which arise from ascending vasa recta and others 
from short vessels draining the subcortical capillaries. These 
channels drain into the interlobar and renal veins.
The macroscopic appearance of the kidneys of rats of different ages 
are described in Table 12. Abnormalities occur more frequently in 
male than in female animals. The most common abnormality is a vary­
ing degree of cortical scarring (Fig. 4) . Even young animals show this
to some extent, and in animals of 17 weeks of age, four percent 
show this feature. By 8 2 weeks of age 29 percent of male and 12 per-, 
cent of females show varying degrees of cortical scarring. Enlarge­
ment of the kidneys is seen only as a feature of age, and in rats of 
over 100 weeks about 19 percent of male animals show enlargement 
of the kidney. A pallor of the kidney is noticed in a few animals 
from 82 weeks of age.
Mild dilatation of the pelvic cavity was seen in a small number of 
young and old rats. True hydronephrosis, which implies pelvic 
dilatation and atrophic parenchymal changes as a consequence of 
obstruction, was not seen in this strain of Sprague-Dawley rat.
Cysts, within the kidney, are also a rare feature and occur occasion­
ally in very old rats (Fig. 5). At 82 weeks, 65 percent of males
and 85 percent of females have normal kidneys, and at 108 weeks 
46 percent of males and 89 percent of females have normal- 
appearing kidneys.
: 4 6 :
Fig. 4. Diffuse cortical scarring. The capsular surface is 
irregular and the fine granularity of the normal kidney has 
disappeared.
:47
Fig. 5. Longitudinal section of a severely scarred 
kidney. The zonation is obliterated. A cyst is present 
beneath the subcapsular cortex.
:48:
TABLE 12
Macroscopic post-mortem findings in male and female rats
17
AGE OF RATS (weeks) 
30 56 82 108
cf ? (f ? (f ? (f %
NUMBER OF RATS 
EXAMINED 100 100 100 100 91 91. 100 100 100 IOC
N.A.D. 96 95 98 91 87 84 65 85 46 89
Cortical scarring 
+ 4 3 1 9 1 3 24 8 23 8
++ 0 1 0 0 3 2 3 2 17 3
+++ 0 0 0 0 0 0 2 2 5 1
Enlargement 0 0 0 0 1 1 3 0 19 1
Pallor 0 0 0 0 0 0 3 3 9 3
Hydronephrosis 0 1 1 0 2 0 2 1 0 0
Cysts 0 0 0 0 0 0 1 1 1 2
Capsular adhesion 0 0 0 0 0 0 1 1 0 0
Cortical nodule 0 0 0 0 0 0 ^ 0 0 1 1
Congestion 0 0 0 0 0 2 0 0 0 0
Mass 0 0 0 0 0 0 1 0 0 0






The nephron of the rat is histologically similar to that of other 
species. The four prominent zones seen macroscopically are 
identified by predominant segments of the nephron. The cortical 
zone shows glomeruli and proximal convoluted tubules, the subcortical 
zone shows straight portions of proximal tubules and broad 
ascending limbs of Henle, the outer medullary zone is composed 
mainly of broad ascending limbs, and the inner medullary zone or 
papilla shows loops of Henle and collecting ducts.
Three types of nephrons have been identified depending on the depth 
to which the loop of Henle descends into the medulla (McFarlane,
1941). Few, if any, loops of Henle are present at the tip of the 
papilla (Kriz, 1967).
The microscopic appearance of the kidneys of rats of different ages 
is described in Table 13.
Chronic progressive nephropathy was the most important finding. 
Thickening of the glomerular basement membrane was the earliest 
change which occurs in this condition and affected glomerular changes 
include enlargement of the glomerular tuft with segmental or global 
sclerosis and capsular adhesions. Eventually complete fibrosis of 
the glomerulus usually occurs. Occasionally, cystic dilatation of 
Bowman's space and atrophy of glomerular capillaries is also seen. 
Both early and late glomerular changes may be seen simultaneously in 
the same kidney. Along with these progressive changes, thickening 
of the basement membranes of tubules, tubular atrophy or dilatation 
of tubules with colloid, interstitial fibrosis and mononuclear cell 
infiltrations occur. In severely affected kidneys these changes are 
distributed diffusely and renal secondary hyperparathyroidism, with
: 50:
mineralised deposits in the gastrointestinal tract, lungs, kidneys 
and media of large arteries may be seen.
The incidence and degree of chronic progressive nephropathy has 
been further classified in Table 14. The earliest changes are 
first encountered in rats of 30 weeks of age. Male rats are more 
severely affected than females. After 108 weeks, 15% of male 
and 2% of female rats showed diffuse changes and effacement of 
their renal architecture. For comparison, transverse sections 
of a normal kidney (Fig. 6 ) and a kidney with marked chronic 
progressive nephropathy (Fig. 7) are shown.
Basophilic tubules, often filled with colloid, are encountered 
primarily in the cortex of the rats and this becomes more 
frequently apparent approaching week 82. The incidence of mono­
nuclear cell infiltrations declines with age from week 30 onwards. 
Mineralised foci in the cortex and medulla appear to be a female 
sex-related phenomenon. Foci of mineralisation in the pelvic 
cavity appear sporadically in male, but only in aged female, rats. 
Urothelial hyperplasia appears to be age-related in both sexes. 
Other changes occurring at a low incidence included a liposarcoma, 
cortical scarring and cysts; the neoplasms were seen only in aged 
rats. Hydronephrosis showed no age-related incidence.
Only six per cent of male rats and 26 per cent of female rats 
showed no renal abnormalities when killed after two years on study,
;51:
TABLE 13
Summary of the microscopic examination of the kidneys of rats
a g e  o f r a t s (weeks)
17 30 56 8 2 108
NUMBER OF RATS EXAMINED 100 100 100 100 55 55 100 100 100 100
NUMBER OF RATS WITH:
No abnormality detected 59 7 2 52 70 19 19 21 49 6 26
Chronic progressive neph­
ropathy O O 4 4 12 8 47 25 81 44
Basophilic/distended cortical
tubules - colloid 21 7 22 8 18 15 34 22 9 6
Basophilic/distended medullary
tubules - colloid 1 0  2 0 1 1 4  6 0 0
Interstitial cortical mono­
nuclear cell foci 18 18 38 21 13 12 21 10 8 10
Foci of mineralisation in
cortex and/or medulla 2 5  2 7  3 10 1 9 0 4
Foci of mineralisation within
pelvic cavity 1 0  2 0 0 0 0 5 1 4
Focal urothelial hyperplasia 0 0  0 0 0 2 4  2 7  5
Cortical scarring or chronic
pyelonephritis 0 0  0 0 0 0 3  1 0 1
Cortical cysts 0 0  0 0 0 0 3 1  2 3
Miscellaneous findings :
Vascular congestion 0 0  0 0 3  2 0 0 0 0
Dilatation of pelvic cavity
(hydronephrosis) 1 1  1 0 0 0 1 0 0 0
Focal suppurative nephritis 0 0  0 1 0 0 1 0  2 0
Papillary/Peripelvic subepithelial
mononuclear cell infiltration 1 0  0 0 0 0 0 0 1 0
:52:
TABLE 13 (continued)
Summary of the microscopic examination of the kidneys of rats
AGE OF RATS (weeks)
17 30 56 82
9 (f ? (f ?
108 
Cf 9




Generalised lymphosarcoma 0 O
0 0 1 0 0 0 0 0
0 0 0 0 1 0 0 0  
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Fig. 6 . Transverse section of a normal kidney 
from a rat aged 30 weeks (H&E) .
: 55 :
Fig. 7. Transverse section of a kidney with marked chronic 
progressive nephropathy, rat 108 weeks old. Kidney enlarged 
and architecture distorted by colloid-filled tubules.
(H&E, same magnification as in Fig. 6 ).
: 56 :
1.5 Discussion
The methods of examining renal function are based on those applicable 
to man, but because toxicological studies concern groups of animals, 
the techniques adopted should be not too time-consuming and should 
be applicable to the unanaesthetised animal. Urine samples can be 
obtained in such a manner as to fulfil these requirements, although 
the volume of urine obtained is dependent upon how long rats may be 
kept without food and water without detriment to their health. Blood 
samples are obtained from lightly anaesthetised animals, although 
the volume collected is limited to avoid circulatory disturbances.
The procedures to assess renal function lack specificity but give 
an overall indication of renal integrity . Clearance studies are 
not applicable to toxicological studies, for they require simultaneous 
infusion and blood or urine collection (Foulkes and Hammond, 1975).
Considerable reliance is placed on serum/plasma urea values. Plasma 
urea concentrations are of value only in assessing profound changes 
of renal damage (Sharratt, 1970; Diezi and Biollaz, 1979). The increase 
in plasma urea with age implies that the interpretation of the relevance 
of a raised group mean plasma urea concentratioh in small numbers of old 
rats may be difficult. There is some indication that plasma creatinine 
might be of more diagnostic value, although not enough data are yet 
available to validate the use of creatinine as a means of assessing 
nephrotoxicity in-the rat. In man, plasma creatinine is of more value 
as an indicator of renal damage than are either creatinine clearance 
or plasma urea concentrations (Morgan et al., 1977; 1978).
Water balance, that is water intake as measured against urinary 
output, is a useful indicator of renal function. Data from male rats, 
in particular between 82 weeks and 108 weeks, must be interpreted 
with caution, because it is evident that the rats with the more severe 
chronic progressive nephropathy die at an earlier age. The
;57:
interpretation of the routine urinalysis is complicated by the fact 
that proteinuria occurs spontaneously in rats.
The urinary enzymes are of interest in nephrotoxicity. Enzymes 
originating from membranes, cytoplasm, mitochondria and lysosomes 
have been assayed following nephrotoxic treatment, in order to 
identify the cell target area and the progress of damage to the 
cell (Wright and Plummer, 1974; Plummer et al., 1979),
Alkaline phosphatase or maltase CStroo and Hook, 1977) or increased 
gamma glutamyl transpeptidase (Braun et al., 1978) originate from 
cell membrane damage of the proximal tubules. Lactate dehydrogen­
ase from the cytoplasm has been shown to be a sensitive indication 
of nephrotoxic damage (Wright and Plummer, 1974; Plummer et al.,
1979; Wachsmuth and Wirz, 1979). Glutamate dehydrogenase from the 
mitochondria was slightly increased in rats given cephaloridine 
(Plummer et al., 1979). Beta-galactosidase, n-acetyl-beta-glucosam- 
inidase, beta-glucosidase, beta-glucuronidase, and acid phosphatase 
are some of the lysosomal enzymes which have been assayed to detect 
nephrotoxicity in the rat (Wright and Plummer, 1974; Ellis and Pric^ 
1975; Raab et al., 1976).
Of these urinary enzymes, the activity of gamma glutamyl transpep­
tidase appears to be worthy of consideration. The enzyme is stable 
at room temperature, and does not require dialysis (as does alkaline 
phosphatase), and appears to be present only in the kidney of rats in 
large quantities CClampitt and Hart, 1978). If urine samples are to be 
collected for urinary enzymes, it is necessary that water is freely 
available to give a good enzyme yield. Glucosuria, although not a 
specific indicator of nephrotoxicity, can give early evidence of 
kidney damage. Glucosuria is the earliest evidence of nephrotoxicity
:58î
induced by a platinum compound in the rat (Pierce et al., 1979). It 
seems more appropriate to measure glucose concentrations in the 
urine than the more usual examination for total reducing substances r 
which is less specific and also less sensitive.
The microscopic examination of freshly voided urine for cells, 
organisms, casts and abnormal constituents, is considered to 
be the best diagnostic test for the classification of renal disease 
in man (Harvey, 1980). The cytology of urinary sediments, stained 
with haematoxylin and eosin, in rats given different nephrotoxic 
agents, was correlated with histological changes observed in the 
kidney by Kennedy and Saluga (1970). Other histochemical staining 
techniques have been employed to facilitate the identification of 
cells in the urine. The high succinic dehydrogenase activity found 
in renal tubular cells, originating from the proximal and distal 
convoluted tubules and ascending and descending limbs of Henle, 
were shown to be useful means of detecting these cells in the urine 
(Hardy, 1968; 1970). Other staining methods used include the 
Papanicolaou stain (Sharratt, 1970) and a peroxidase stain 
(Prescott and Brodie, 1964). Hardy (1968) quantified the cells 
in urine following nephrotoxic damage and later commented that 
cells may appear in the urine of rats given non-nephrotoxic substan­
ces such- as urea, lactose and caffeine (Hardy, 1970).
The histological characteristics and the age- and sex-related 
features of chronic progressive nephropathy described in this 
survey, agree with those recorded by other workers (Gray, 1977; 
Barthold, 1979) . So many variables affect the age of onset and 
progression of chronic progressive nephropathy, that different 
strains of rats, or rats kept under different laboratory conditions.
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can not be compared. This survey confirms the low incidence of 
renal tumours in Sprague-Dawley rats (Bullock and Curtis, 19 30;
Ross and Bras, 1965; Snell, 1967).
Techniques such as electron microscopy and histochemistry could be 
applied to the study of nephrotoxicity, but these are specific tools 
for the detection of changes in cells, rather than of changes in 
organs.
The main conclusion of this survey is that chronic progressive 
nephropathy is the major background pathology, against which we must 
interpret toxicological change.
:60:
P A R T T W O
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2. The renal effects of short-term administration of aspirin and 
phenylbutazone
Surprisingly there is a very limited literature on the nephrotoxicity, 
in the rat, of the more commonly used non-steroidal anti-inflammatory 
compounds. A series of experiments was planned to investigate the 
development of renal lesions in the rat, and to investigate the 
effects of age and sex, on the development of these lesions. Aspirin 
and phenylbutazone were chosen for investigation.
2.1 Experiment 1
Arnold et al. (1973 a and b) recorded that single doses of aspirin 
given to Wistar rats, induced necrosis of segments of the proximal 
convoluted tubules, with subsequent regeneration and tolerance of 
further doses of aspirin.
An experiment was designed in order to observe these necrotic and 
regenerative changes. The dose level of 300 mg/kg was selected because 
it was one fifth of the LD50 value. '
2.1.1 Materials and methods
Sixty male and sixty female Sprague-Dawley rats of the CFY strain were 
obtained. The rats were six weeks of age when single doses of aspirin 
were administered at the dosage level of 300 mg/kg by oral gavage in 
1 % methyl cellulose at a dosage volume of 1 ml per 1 0 0 g body weight. 
Forty males and forty females received aspirin, and twenty male and 
twenty female rats received methyl cellulose only and acted as 
controls. Groups of ten male and ten female treated animals.
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together with five male and five female control animals, were 
killed after 24, 48, 72 and 96 hours. The rats were subjected to full 
macroscopic post mortem examination; the kidneys were weighed and 
kidney tissue was taken for subsequent histological examination.
2.1.2 Results
None of the rats died as a result of the aspirin treatment and no 
macroscopic abnormalities were encountered at post mortem 
examination. The kidney weights are presented in Table 15. The male 
rats killed at 48, 72 and 96 hours after treatment showed a marginal 
increase in kidney weights. The female animals had increased 
kidney weights after 24 hours only.
The histological examination of the kidney did not show signs of 
necrotic change. The mitotic figures in anaphase and telophase (Fig:8) 
in the pars recta of the renal proximal tubules were counted in 
the kidneys of control and treated rats and the results are 
presented in Table 16. The mitotic figures appeared to be more 
prominent in rats that had received aspirin. In both male and 
female rats killed after 24 hours, the aspirin-treated rats showed 
six or more mitotic figures in the phases defined; this effect was 
not noted at 48, 72 or 96 hours after dosing.
2.1.3 Discussion
The results do not support the observations of Arnold (_1973a and b) 
It is surprising that frank necrotic changes were not encountered, 
but limited evidence of a nephrotoxic effect is indicated by the 
higher mitotic index in the treated animals.
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Fig. 8 . Rat kidney, pars recta of proximal convoluted 
tubule. Two mitotic figures in telophase (arrows)
(H&E X  600).
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TABLE 15
Group mean bodyweights and kidney weights of rats killed at 24, 48 
72 or 96 hours after receiving aspirin
Time and
aspirin dose Number BODYWEIGHT (g) KIDNEY WEIGHT (s)
level (mg/kg) of rats Mean + SD Mean + .SD
24 hours
Male 0 5 208 + 14 2.53 + 0.16
Male 300 1 0 202 + 16 2.47 + 0.23
Female 0 5 165 + 23 1.89 + 0.33
Female 300 1 0 177 + 15 2.19 + 0.18
48 hours
Male 0 5 213 + 26 2.50 + 0.26
Male 300 1 0 2 1 1 + 14 2.55 + 0.19
Female 0 5 190 + -.6 2.25 + 0.19
Female 300 1 0 181 + .11 2.09 + 0.23
72 hours 
Male 0 5 219 + 17 2.43 + 0.29
Male 300 1 0 230 + 20 .2.62 + 0.24
Female 0 5 181 + 11 2 . 0 0 + 0.13
Female 300 1 0 190 + 17 2.06 + 0.17
96 hours
Male 0 5 227 + 16 2.49 + 0.15
Male 300 1 0 229 + 19 2.64 + 0.29
Female 0 5 185 + 20 2.05 + 0 . 2 2
Female 300 1 0 190 + 15 2.07 + 0.23
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TABLE 16
Number of mitotic figures encountered in renal tubules of rats 
killed at 24, 48, 72 or 96 hours after receiving aspirin
Total Number of rats with mitotic figures
.n cose number in kidneys; 
level (mg/kg) of rats O 1-5 6-10 11-15 16-20 21-25 25-30 31-35 36-40
MALE
24 / 0 5 2 3 - - - - - - -
300 1 0 0 2 5 2 - 1 - - -
48 / 0 5 3 2 - - - - - - -
300 10 3 7 - - - - - - -
72 / 0 5 2 3 - - - - - - -
300 1 0 5 5 - - - - - - -
96 / 0 5 5 - - - - - - - -
300 10 1 0 - - - - - - - -
FEMALE
2 4 / 0
300
4 8 / 0
300
7 2 / 0
300
















As single doses of aspirin had failed to induce morphological 
evidence of nephrotoxicity, a second experiment was designed to 
investigate repeat doses of aspirin. It was decided to investigate 
effects in young and adult animals. The experiment was planned to 
last for ten days.
2.2.1 Materials and methods
Forty Sprague-Dawley rats of the CFY strain, equally divided with 
respect to sex, were obtained at 28 days of age. The animals were 
maintained under standard conditions as described in the Appendix.
The animals were divided into two groups of 10 male and 10 female 
animals: the first group was for immediate experiment and the others 
were allowed to grow until they reached the age of 20 weeks. Five 
male and five female rats from each group received aspirin, 
suspended in 1 .0 % methylcellulose, by oral gavage once daily, at a 
dosage volume of 1 ml per 1 0 0 g body weight,at ,the dosage level of 
300 mg/kg/day. The other five male and five female rats in each group 
received 1 .0 % methylcellulose at the dosage volume of 1 ml per 1 0 0  g
body weight, and acted as the controls. The first group started 
dosing at 6 weeks of age and the second group started dosing at 20  
weeks of age.
The rats were examined before treatment started, and several times 
daily during the course of the experiment. Body weight changes and 
food and water consumption were monitored throughout the experiment.
After the first dose, rats were individually placed in metabolism 
cages, fitted with faecal separators, with water freely available 
but food withdrawn. Urine samples were collected over a 24-hour
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period. The volume of urine voided and the concentration of 
alkaline phosphatase, lactate dehydrogenase and aspartate amino­
transferase were measured. After the final dose on day 10, the 
rats were placed in metabolism cages and both food and water were 
withdrawn. Overnight 18-hour urine samples were examined for volume, 
specific gravity, pH, protein concentration, semi-quantitative 
determinations and microscopy. Blood was taken from rats in the 
control and treated groups, for determination of plasma urea values. 
On day 11 the rats were killed and given a full macroscopic 
examination, together with kidney weight measurements; samples of 
the kidney were preserved in formalin and prepared for subsequent 
histological examination.
2.2.2 Results
No rats died during the treatment period. The body weight changes 
are shown in Figure 9. The young female rats were apparently 
unaffected by treatment: however, the young males showed depression of 
body weight gain over the entire experimental period. All the older 
rats, most notably the aspirin-treated rats, lost weight from day 
1 to day 4 of the experiment and then recovered their pre-dose 
body weight by the end of the treatment period.
The amount of food and water consumed is presented in Table 17. 
Although no differences can be detected in the food intake between 
the groups, aspirin-treated rats drank more water than the 
controls. This applied particularly to the older rats.
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7 8 9 10 days of treatment
Fig. 9. Growth of control and treated young and aged rats
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TABLE 17
Total amount of food and water consumed per group during ten day 
treatment period
Aspirin
dose level YOUNG RATS OLD RATS
mg/kg/day WATER (mis) (5* 9 cf 9-
1514 1397 1150 1190
300 1918 1826 2360 2423
FOOD (g)
O 905 665 970 785
300 950 660 980 860
:70:
The volume of urine voided by the treated rats over the 24-hour 
period after receiving the first dose, was much greater in animals 
dosed with aspirin than in the controls. Differences between the 
group means were statistically significant in the older animals 
(Table 18). The enzymes liberated in the urine samples over the 
24-hour period are listed in Table 19. Although the results show 
considerable individual variation, some generalisation can be made. 
In the young rats, only the alkaline phosphatase was increased by 
treatment, whereas in the older rats alkaline phosphatase and 
aspartate aminotransferase levels were raised. The results of the 
terminal urine analysis are presented in Table 20. The young rats 
voided larger volumes of urine of low specific gravity, whereas 
the older rats voided urine containing more protein than did the 
controls.
The absolute and relative kidney weights are shown in Table 21: the 
results show a trend for increased kidney weight in treated rats. 
Macroscopic and microscopic examination of the kidneys showed no 
lesions that could be attributed to aspirin treatment.
2.2.3 Discussion
Impaired growth in young male rats might be due to gastric 
mucosal damage induced by aspirin (John, 1975). Kadokawa et al. 
(1979) reported that, in male Wistar rats, aspirin at the dosage 
level of 30-300 mg/kg/day decreased urinary volume and caused 
sodium and water retention, while Plummer et al. (1975) reported 
that 200 mg/kg/day, administered to Wistar rats, caused a consistent 
increase in the volume of the urine voided. This experiment showed 
that, in the Sprague-Dawley rat, aspirin causes increased water 
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Raab (1968; 1969) found that single doses of aspirin caused an 
enzymuria with increased AP and LDH activity. The results tend to 
confirm the increased activity of alkaline phosphatase and, in older 
rats, aspartate aminotransferase (AsT).
Increased kidney weight in the absence of morphological change can 
be interpreted only as an adaptive response. The absence of 
morphological change after 10 days of drug administration is 
consistent with the regeneration and tolerance that Arnold (1973 a 
and b) found after single or repeat dosing with aspirin.
2.3 Experiment 3
The absence of pathological findings from the first two experiments 
prompted a further experiment with higher dosage levels.
2.3.1. Materials and methods
Male Sprague-Dawley rats of the CFY strain were used for this 
experiment. There were 15 rats per group, receiving aspirin at 
the dosage level of 500 mg/kg/day. Fifteen rats were given methyl­
cellulose orally, and acted as controls. Five rats from the dosed 
group and the control group received one dose only, then were placed 
in metabolism cages for 24-hour urine collections; thereafter the 
animals were bled and killed for macroscopic examination. The other 
10 animals per group were dosed for 10 consecutive days. After the 
final dose, urine was collected overnight and the animals bled and 
killed for post mortem examination. The urine samples collected over
: 79 :
the 24-hour period after a single dose, and the urine samples 
collected at the end of the study after 16 hours of water 
deprivation, were assayed for enzymes, LDH, AsT and gamma-GT. The 
standard urinalysis was performed and plasma urea was estimated.
2.3.2 Results
The rats dosed with aspirin for ten days showed no untoward clinical 
signs but body weight gain was suppressed (Fig, 10). Food consumption 
was not affected by the administration of aspirin, bat water 
consumption._was increased to...38 mis (24-51 mis) per rat per jdayr
controls 28 mis (25-33 mis) per rat per day.
The urine volume voided following the first dose of aspirin was 
increased. The amounts of enzymes voided over a 24-hour period is 
shown in Table 22. All significant changes following the adminis­
tration of aspirin were found in one rat only.
One rat, which was killed 24 hours after the first dose of 500 mg/kg
aspirin, showed a few necrotic proximal convoluted tubules (Fig. 11).This 
was associated with increased urinary enzyme activity, together with 
proteinuria, glucosuria, and the presence of total reducing substan­
ces in the urine. ’ The other animals killed at this time showed no 
histopathological changes indicative of nephrotoxicity.
After 10 days' dosing with 500 mg/kg/day aspirin, the examination of 
the urine samples showed little difference between control and treated 
rats. Urinary volumes and specific gravity were similar to controls. 
There was a slight increase in the amount of protein in the urine in 
treated animals. The plasma urea values are presented in Table 23, 
and they show a marginal increase following treatment with aspirin.
:80:















( ' I I I
1 2  3 4
I — 1
8 9 days of treatment
Fig. 10. Growth of control and treated rats.
:81:
p
Fig. 11. Necrotic loops of proximal convoluted tubules 
in a rat receiving a single dose of aspirin (500 mg/kg) 
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Group mean plasma urea concentration after ten day's treatment
Aspirin dose level Plasma urea concentration mg/%
mg/kg Mean - SD Range
34 ± 3 3 1 - 3 6













0) o 1— i
cr 1 1
Eh T3 c o 00







Z CO o in CNa AJ CQ O r4
H
ui AD CD o
<U
M CO +  1
> CO + 1 +1H 0)
Eh
< a c m n
X .A3 œ O
H (U
K 2 O 1-4
EhCO ffi 1-4 TfCD G>1 H CP CN CN
A3 W G 1 1
T3 Z G VO 00PS
C >H t-4 1*40) M
+J Z
Q COH •iE O CN 1-40) G CQ r4 CN4J )444 M Ü1 6 O
A3 Eh + 1
D + 1 4-1CO iX4-) O G VO m
g CQ : G 00 O
m G
•H < 2 r4 CN0)
00 Tf(U G CN TT
c . CP CN CNAD G 1 1
•H G m OPS <Ti 001*4 1-4
ADG
A3 œ Q
CD CQ r" VOCO H CO r4 1*4+J H E
x: Z G + 1 + 1 4-1CP tH 34
•H Q O'cu O G Tf CNm G r4 O0) CN CN
AD 20XI
c rH
A3 G(U >E G (U•H 1-4a 34 (P O0 •H 0) X O oo CL W \ mCO 0 CP
CD < AD E
: 85 :
The kidney weights were slightly increased by treatment for 10 days 
when compared with the controls (Table 24). No treatment-related 
changes were found on macroscopic examination of the kidneys. No 
other microscopic change was seen that could be attributed to 
treatment with the test compound.
2.3.3 Discussion
The study essentially confirmed the findings of the first two 
experiments. The effects on water consumption and the amounts 
of urine voided were essentially the same as in the first 
experiment. The urinary enzymes were found to be of little 
diagnostic value other than detecting frank necrotic changes.
Only one rat dosed with aspirin developed morphological evidence 
of nephrotoxicity, similar to that previously attributed to doses 
of aspirin of 100-900 mg/kg (Arnold, 1973a and b ) .
2.4 Experiment 4
The failure clearly to define nephrotoxicity at these high dosage 
levels prompted a further experiment in which aspirin was 
administered at the dosage level of 750 mg/kg/day for three days.
: 86 :
2.4.1 Materials and methods
Fifteen male rats of the Sprague-Dawley CFY strain were given 
aspirin by the oral route at the dosage level of 750 mg/kg/day.
Five rats were killed 24 hours after receiving the first dose, a 
further five rats were killed 24 hours after receiving the second 
dose and the remaining five rats were killed 24 hours after the 
third dose. Fifteen male rats were given methylcellulose at the 
same dosage volume as the treated rats and acted as controls. Urine 
samples were taken throughout the course of the study with water 
freely available on all occasions. Immediately before the animals 
were killed, blood samples were taken for plasma urea determinations; 
after subsequent macroscopic post mortem examination the kidneys 
were preserved for histopathological examination.
2.4.2 Results
No animals died during the course of the experiment. The aspirin 
treated rats consistently voided more urine than controls. The 
levels of the urinary enzymes are given in Table 25: the enzyme 
activity in the urine samples varied throughout the dosing period 
and no clear trend is apparent. The plasma urea values show a 
distinct trend to increase with successive doses (Table 26).
The kidney weights were slightly increased compared with those of 
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Group mean plasma urea concentrations after first, second and third 
doses of aspirin
èspirin p l a s m a  UREA CONCENTRATION
dose_leyel mg/%
mg/kg/day Mean + SD Range
FIRST DOSE 0 34 + 3 31 - 36
750 36 + 8 28 - 47
SECOND DOSE 0 63 + 2 60 — 66
750 47 + 8 38 - 57
THIRD DOSE 0 49 + 7 43 - 60
750 1 1 0 + 68 64 - 188
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2.4.3 Discussion
Even by using high dose levels of aspirin, the findings of Arnold 
1973; a and b) could not be substantiated, although the increase 
in plasma urea and the increase in kidney weight suggests some 
renal impairment.
2.5 Experiment 5
The failure reliably to induce nephrotoxicity in the Sprague- 
Dawley s t r i 3rbmi3t ^ . â  survey of a series of experiments, 
in which aspirin in 1 % methylcellulose had been given to rats at 
various dose levels. The CFY strain of Sprague-Dawley rat has 
ceased to be available because of disease and therefore the survey 
was restricted to Sprague-Dawley rats of the Charles River CD 
strain.
2.5.1 Materials and methods
The material surveyed was from rats of the CD strain, the rats 
varied in age, although all were young adolescent animals. The rats 
had been given single doses of aspirin and killed approximately 18 









Dying With necrosis of proximal 
convoluted tubules
MALE
0 Control 5 0 0
500 Aspirin 5 0 0
1 0 0 0 Aspirin 5 0 0
1 2 0 0 Aspirin 5 1 0










Aspirin given by oral gavage in 1.0% methylcellulose at 
a dosage volume of 1 ml/100 g bodyweight. Control rats 
received 1 .0 % methylcellulose at 1 ml/ 1 0 0 g bodyweight.
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2.5.2 Results
The results of this survey are presented in Table 27, and show 
that necrosis of the proximal convoluted tubules could be detected
2.5.3 Discussion
The survey indicates that female rats were susceptible to the 
nephrotoxic action of aspirin at high dose levels. Male animals 
appeared not be be susceptible. At the dose level of 1000 mg/kg an 
apparent 100% effect is obtained. The data suggest that the CFY 
Sprague-Dawley strain was less susceptible to aspirin than the CD 
Sprague-Dawley rat.
2 .6 Experiment 6
An experiment was designed to investigate the observed female sex- 
related susceptibility to single doses of aspirin. In this 
experiment, sexually immature and sexually mature female rats 
received single doses of 1 0 0 0  mg/kg of aspirin.
2.6.1 Materials and methods
Twenty female 28-day-old Sprague-Dawley rats of the CD strain, 
weighing between 78 and 84 g, were obtained and maintained under 
standard conditions. The animals were divided into two groups of 
ten, the first group to be treated at 31 days of age, while the
;92i
second group was allowed to mature and was treated at 55
days of age. Five rats from each group were given aspirin suspended
in 1 % methyl cellulose, by oral gavage at the dosage level of 1 0 0 0 mg/kg
in a dosage volume of 1 ml per 100 g body weight. Five rats
from each group received a vehicle and acted as the controls. The 
rats were examined before dosing, and after dosing were placed in 
metabolism cages fitted with faecal separators, with food witheld 
but with water freely available. Urine samples were collected from 
each rat for an overnight period of 18-hours. The urine samples were 
examined for volume, specific gravity, pH, osmolality, protein 
concentration, gamma-GT activity.
Samples of blood were taken from the orbital sinus of the control 
and treated rats under light ether anaesthesia for determination of 
plasma urea and creatinine, and serum gamma-GT activity. The rats 
were subsequently killed, examined macroscopically and samples of 
the kidneys preserved and prepared for histological examination.
2.6.2 Results
The immature rats appeared not to have been affected by the treatment. 
Two of the sexually mature rats died during the experimental period.
The results of the various test procedures are presented in Table 28. 
Plasma urea values were marginally raised in the immature animals 
but were markedly increased in the mature animals. Plasma creatinine 
did not appear to be affected by the treatment. The urine volume voided 
was slightly increased in the dosed animals but the osmolality was 
markedly increased in the sexually mature animals. Marked proteinuria 
was evident in the mature female animals. The urinary gamma-GT was 
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Histopathological change was detected in the kidneys of all mature 
animals that had been treated with aspirin. In some of these rats, 
up to 25% of the cortex was affected. Lesions were mainly confined 
to the pars recta of the proximal convoluted tubules and characterised 
by segmental loss of the normal architecture of the epithelium which 
was replaced by an eosinophilic amorphous plug surrounded by 
basement membrane. In other areas epithelial cells showed nuclear 
pyknosis, karyorrhexis and karyolysis with more intensely staining 
eosinophilic cytoplasm [Fig.12). Occasionally tubules in the medulla 
were dilated by amorphous plugs of material of a similar appearance 
to the cellular debris in the cortex. These changes were not seen in 
immature treated rats or control rats.
2.6.3 Discussion
The results of this experiment support the hypothesis that nephro­
toxicity can be induced only in sexually mature rats. Sprague-Dawley 
rats have their first oestrus cycle at 42-49 days of age CLane- 
Petter, 1972). The results here show that they become susceptible 
to the nephrotoxic effects of aspirin by day 55'.
2.7 Experiment 7
Previous studies had indicated that sexually mature female rats were 
more susceptible than males and immature females to the renal toxicity 
of aspirin. In order to investigate the role of oestrogens on the 
analgesic-induced renal toxicity in rodents, an experiment was carried 
out on castrated males, pretreated with ethinyl oestradiol.
: 95 :
d î ' i - .  X '
» %. t
X  ft V
Fig. 12. Several necrotic remnants of proximal tubules 
containing amorphous debris surrounded by a fine basement 
membrane. A few dark pyknotic nuclei are oresent in 
adjacent tubules CH&E x 315).
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2.7.1 Materials and methods
Four-week-old male and female Sprague-Dawley rats of the CD strain 
were allocated to five experimental groups as shown in Table 2 9.
The rats were housed under the standard conditions.
The males were castrated under etorphine hydrochloride (Immobilon: 
small animal; Reckitt and Colman) anaesthesia CO.074 mg/kg) with 
subsequent suturing and closure of the inguinal canal.
The rats were untreated for nine weeks following the castration 
procedure. Groups three and five were given ethinyl oestradiol 
at a dose level of 0.05 mg/kg/day for four weeks. Single doses of 
1 0 0 0 mg/kg of aspirin were given to groups two, four and five.
Groups one and three acted as controls. The aspirin was given by
oral gavage at a dosage volume of 1 ml per 100 g body weight. The 
rats were 17 weeks of age at the time of drug administration.
After being given aspirin, the rats were individually housed in 
metabolism cages fitted with faecal separators, with water freely 
available but food witheld. Urine samples were collected for 18 
hours and were examined routinely for volume, specific gravity, pH, 
protein concentration, osmolality and gamma-glutamyl transpeptidase 
activity.
The rats were maintained for 18 to 24 hours after dosing: all 
surviving rats were subsequently bled from the orbital sinus and serum 
blood samples were analysed for plasma urea and creatinine and 
gamma-glutamyl transpeptidase. The rats were killed and, during
post mortem examination, a slice of the right kidney was snap-
frozen in n-hexane cooled to minus 70°C for histochemical examina­
tion of gamma-glutamyl transpeptidase acivity CGlenner and Folk,









fO CO d)e d) M-l
CO (d p




(d O'e s + 1 d)
CO en
(d (d c 3iH (U (d (d





e n3-Hœ > 1E h
g
Q
P h e uO 30« PW O 'O Q
S pD d)Z P U
4J3d)g4J(dd)-P pC E h
:+ 3(dd)PE h X
d)' V e n3rd
Û 4 e u3 30 OP pO o
r—1OEh p01 +J3









II II II II II
3 3 3 3 3
O VO un CN en
O O 00 VO inrH CN rH rH
00 00
CN VO rH VO m VO CN n VO O
m 00 m 00 VO
+  1 1 +  1 1 +  1 1 +  1 1 +  1 1(N in 00 r"TT m O O' CN m CN CN TT
en f'' CN if) Lf)
O m VO 00 CN







< -pCO-t- + od) d)rH 3 rH -p 3 4J r40 •H o td •H (d >1p P p P p p 3+J •H jj -P •H -p •H3 eu 3 CO eu CO0 CO 0 (d CO cd +J


















Two animals from group two and one animal from groups four and 
five died after dosing with aspirin. Macroscopic post mortem 
examination failed to establish the cause of death. The urine 
volume, plasma creatinine concentration and serum gamma-glutamyl 
transpeptidase activity appeared to be unaffected by treatment with 
aspirin. Increased urine specific gravity, osmolality, protein 
concentration and lowered pH were found after administration of 
aspirin. The results are presented in Table 30.
Urinary gamma-glutconyl transpeptidase activity and plasma urea values 
were increased in the rats given aspirin. In rats given aspirin 
only, there were signs of focal necrosis of the loops of the 
proximal convoluted tubules with mineralised necrotic debris within 
the lumen of cortical and medullary tubules <Fig^13).The results are 
presented in Table 29. Histochemical examination of the renal 
tissues showed that the highest concentration of gamma-glutamyl 
transpeptidase was found within the cytoplasm of epithelial cells of 
proximal convoluted tubules, and in the rats with necrotic changes 
induced by aspirin there was loss of the enzymes from these foci, 
(Fig. 14).
2.7.3 Discussion
These results show that aspirin induces acute cortical tubular 
necrosis in castrated male rats. Pre-treating the castrated rats 
with ethinyl oestradiol causes a slight increase in the extent of 





Fig. 13. Aspirin-induced focal necrosis of proximal convoluted 
tubules, with partially mineralised debris within the lumen 
(H&E X  470).
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Fig. 14. Gamma-glutamyl transpeptidase activity 
concentrated on the luminal surface of proximal 
convoluted tubules. The pale profiles lack activity 
and represent necrotic tubules (Glenner and Folk, 1961) 
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2.8 Experiment 8
This experiment was performed in order to investigate whether 
ethinyl oestradiol treatment alters the susceptibility of the 
kidneys of female rats to aspirin, and to verify the results of 
the previous experiment in which castrated male rats, with or 
without a period of ethinyl oestradiol treatment, became susceptible 
to the nephrotoxic effects of aspirin.
2.8.1 Materials and methods
Four-week-old male and female Sprague-Dawley rats of the CD strain 
were allocated to seven groups, as shown in Table 31. The experim­
ental methods were as for experiment 7, although in this case 
histochemical demonstration of gamma-glutamyl transpeptidase activity 
was not carried out.
2.8.2 Results
None of the rats died as a result of treatment. Urinary volume, 
specific gravity, osmolality, total reducing substances and glucose 
were not affected by aspirin treatment. When compared with their 
respective controls, aspirin-treated rats had slightly lowered pH, 
increased proteinuria and increased urinary gamma-GT activity. The 
amount of the urinary gamma-GT was sex-related, with the females 
liberating the smallest amounts. The results are presented in Table 
32. Plasma urea and creatinine concentrations and serum gamma-GT 
were unaffected by treatment with aspirin. The incidence and extent 
of necrosis of proximal convoluted tubules is set out in Table 31.
:103;
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These results show that aspirin induces acute cortical tubular 
necrosis in male rats sexually modified by castration, and that 
by pre-treating with ethinyl oestradiol, the incidence and extent 
of these lesions is increased.
The effects of ethinyl oestradiol treatment on the female animals 
is more difficult to interpret for, in this experiment, female 
rats dosed with aspirin at the dosage level of 1 0 0 0  mg/kg/day 
failed to develop renal cortical lesions to the extent of 
previous experiments. The failure to induce a standard response 
in a standard strain of rat, makes it impossible to fulfil the 
objectives of the first part of this experiment.
2.9 Experiment 9
The results of previous experiments, together with a review of the 
literature, suggested that the strain of rat might be of importance 
in the susceptibility to nephrotoxic damage induced by aspirin.
The following experiment was designed to investigate this hypo­
thesis. Strain-related susceptibility to analgesic nephropathy 
would have considerable implications in toxicological safety 
evaluation.
2.9.1 Materials and methods
Groups of ten male and ten female rats, aged four weeks, of 
Sprague-Dawley, Lister Hooded and Wistar strains were obtained 
from Olac Limited, Oxon, together with ten male and ten female
; 106 :
Fischer-344 rats from Charles River, USA. The rats were maintained 
under standard conditions. Single doses of aspirin at 1000 mg/kg 
were given to five male and five female rats of each strain, while 
five male and five female rats received the vehicle only and acted 
as controls. The rats were six weeks old at the start of the 
experiment. After dosing, the treated rats and their controls were 
placed in individual metabolism cages with food withheld but water 
freely available. Eighteen-hour overnight urine samples were 
collected and examined for volume, specific gravity, pH, protein 
concentration and gamma-glutamyl transpeptidase, together with 
semiquantitative determinations and microscopy of spun deposits. 
Approximately 24 hours after dosing the animals were killed and 
examined macroscopically, the kidneys were weighed, and samples of 
kidneys were processed for histological examination.
2.9.2 Results
None of the rats receiving aspirin showed any reaction to the 
treatment. The results of the plasma urea and'creatinine values 
are presented in Table 33. Plasma urea values were raised in the 
Sprague-Dawley strain and in the Fischer-344 strain, but particularly 
in the female animals. Plasma creatinine levels were slightly 
raised in the Sprague-Dawley and Lister-Hooded strains, and markedly 
raised in the female Fischer-344 rats. The significant findings 
from the urinalysis are listed in Table 34. The results show that 
significant increases in protein concentration in urine were 
detected in the female rats of the Sprague-Dawley, Lister-Hooded and 
Fischer-344 strains. Gamma-GT values were markedly raised in the 
female animals of all four strains, but the elevation was 
particularly marked in the Fischer-344 strain. Changes in protein 
concentration and gamma-GT could not be detected in male animals.
:107:
TABLE 33




PLASMA UREA (mg %)
MALE
PLASMA CREATININE (mg %)
FEMALE MALE FEMALE




2 5 - 3  
38 i 7
28 i 5 
4 5 - 9
0.74 - 0.09 0.74 - 0.15






3 5 - 7
4 0 - 4
0.72 - 0.04 0.72 - 0.04




3 0 - 2  
41 - 3
36 i 4 
40 - 4
0.72 - 0.04 0.74 - 0.05




32 i 3 
45 i 15
3 7 - 3
170 - 52
0.70 - O 0.70 - O
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Incidence and degree of cortical tubular necrosis in rats 


























+ Minimal - a few tubules 
++ Slight - several tubules 
+++ Moderate - many tubules and confluent areas
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The organ weight data are presented in Table 35, and indicate slight 
increases in the kidney weights in the Sprague-Dawley, Hooded-Lister 
and Wistar strains, in both male and female animals.
The incidence and degree of cortical tubular necrosis is presented 
in Table 36. The data show that all dosed female animals developed 
some degree of bilateral tubular necrosis with an occasional male 
Sprague-Dawley or Lister-Hooded rat being mildly affected. Male 
Fischer rats were affected unilaterally. Male Wistar rats showed no 
abnormalities.
2.9.3 Discussion
The results confirm the previous experiments indicating that the 
female animals are the more susceptible to renal damage, and the 
Fischer-344 is the most susceptible strain. Plasma urea and 
creatinine, together with gamma-glutamyl transpeptidase, showed 
good correlation with the degree of kidney damage.
The data show that two male Sprague-Dawley rats showed mild bilateral 
tubular necrosis, indicating not only strain differences, but also 
differences in substrains, for tubular necrosis is not a feature of 
aspirin toxicity in the male Sprague-Dawley rat of the CD strain.
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2.10 Experiment 10
The non-steroidal anti-inflammatory drugs are inhibitors of 
prostaglandin synthesis. There is evidence that the administration 
of these compounds, increases renal vascular resistance (Chapnick 
et al., 1977). Hypertensive animals may have altered prostaglandin 
synthesis. An experiment was designed to see if the kidneys of 
rats became more susceptible to aspirin when the animals were 
hypertensive. Unfortunately this experiment was carried out in 
male rats, before it was appreciated that a marked sex difference 
for the susceptibility of the kidney existed.
2.10.1 Materials and methods
Hypertensive male rats were allocated to four groups as shown in 
Table 37. Two of the groups were made hypertensive by recognised 
surgical techniques. The Goldblatt method requires the kidney 
to be exteriorised and the renal artery isolated,a silver clip 
C2 mm wide, 0.15 mm thick) is then placed around the artery at the 
hylus and compressed with forceps # The kidney is then restored 
to its original position. The Doca-saline technique requires a 
kidney to be excised, a 50 mg Doca implant (Organon Laboratories 
Limited) to be implanted subcutaneously in the right flank. These 
rats are given 0 .8% sodium chloride, 0 .1 % potasium chloride in 
their drinking water. The Okomoto-Aoki is a strain of spontaneously 
hypertensive rat.
The rats were housed under standard conditions. Blood pressure and 
heart rate were determined indirectly by using an animal blood 
pressure monitor (Huntingdon Instruments), with integral inflatable
:115:
TABLE 37
Summary of treatment groups and mortalities
TYPE OF RAT NUMBER OF RATS RECEIVING:
Vehicle Control 500 mg/kg Aspirin 1000 mg/kg Aspirin






cuff and photoelectric pick-up in the same unit. The pressure and 
heart rates were recorded on a standardized trace using a Devices 
M2 chart recorder with the trace running at 10 mm per second.
Aspirin at dosage levels of either 500 mg/kg or 1000 mg/kg at a 
dose volume of 1 ml per 1 0 0 g body weight was administered to the 
hypertensive animals. Normotensive sham-operated
rats were maintained as controls. Following dosing, the rats were 
placed in metabolism cages with water or saline freely available.
Urine samples were collected over 18 hours and examined for volume, 
specific gravity, pH, protein concentration and gamma-glutamyl 
transpeptidase activity, together with semiquantitative determinations 
and microscopy of spun urine deposits. Two hours after dosing the 
blood pressure and heart rates were monitored. Following the 
overnight collection of urine the surviving animals were bled under 
ether anaesthesia, for plasma urea and creatinine estimations. The 
rats were killed and macroscopic examination made and the kidneys 
were preserved and prepared for histological examination.
2.10.2 Results
Mortalities occurred in all groups but particularly in those animals 
dosed at the level of 1000 mg/kg. The Doca-saline hypertensive rats 
were the most severely affected (Table 37). The blood pressure and 
heart rates are presented in Tables 38 and 39. There was no effect 
on the blood pressure or heart rate. The urinary volume and specific 
gravity were not affected by aspirin treatment, proteinuria showed 
no indication of aspirin-induced nephrotoxicity. Proteinuria was 
a prominent finding in the Goldblatt and Doca-saline hypertensive 
rats. There was no definite effect on gamma-glutamyl transpeptidase 
[Table 40) apart from the sham-operated rats receiving 500 mg/kg 




Group mean blood pressure recordings (mm.Hg)
GROUP AND ASPIRIN PREDOSE 2 HOURS
DOSE LEVEL Systolic Diastolic Systolic Diastolic
Mean - SD Mean - SD Mean - SD Mean - SD
Sham-operated 0 130 - 20 98 - 19 129 - 19 94 - 17
Cn=8 I
500 130 - 10 100 - 9 1 1 9 - 7  88 - 2
Cn=41
1000 124 i 9 90 - 13 121 - 9 8 8 - 1 3
Cn=3L
Goldblatt 0 212 - 28 166 - 24 194 - 40 151 - 36
Cn=8 i
500 232 - 14 177 - 21 207 - 6 172 ̂  3
Cn=3)
1000 202 - 13 160 - 17 211 - 24 166 - 26
(n=7l
Doca-saline 0 212 - 23 162 - 20 194 - 26 152 - 21
Cn=8 )
500 169 - 24 138 - 23 190 - 22 146 - 23
Cn=4).




Group mean blood pressure recordings (mm.Hg)
GROUP AND ASPIRIN PREDOSE 2 HOURS
DOSE LEVEL Systolic Diastolic Systolic Diastolic
Mean - SD Mean - SD Mean - SD Mean - SD
Okomoto/Aoki O 195 - 25 153 - 23 164 - 19 129 - 15
(n=8 )
500 193 - 6 146 i 8 162 - 17 125 - 14
(n=41




Group mean heart rate recordings (beats/min)
GROUP AND ASPIRIN PREDOSE 2 HOURS
DOSE LEVEL Mean + 3Ü. Mean + SD
Sham-operated 0 Cn=8 ) 443 + 53 446 + 63
500 Cn=4I 450 + 28 443 + 64
1 0 0 0 Cn=3) 410 + 26 383 + 50
Goldblatt 0 Cn=8 ) 496 + 66 444 + 62
500 Cn=3} 483 + 45 497 + 83
1 0 0 0 Cn=71 496 + 42 479 + 57
Doca-saline 0 Cn=81 464 + 48 456 + 51
500 Cn=4l 373 + 43 443 + 39
1 0 0 0 Cn=6 ) 417 + 12 418 + 57
Okomoto/Aoki 0 Cn=8 ) 505 + 25 445 + 57
500 Cn=4 i 445 + 68 465 + 53
1 0 0 0 Cn=5) 446 + 50 460 + 42
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TABLE 40
Summary of urinary enzymes and protein concentration
GROUP AND ASPIRIN 0-GT it)U/Volume PROTEIN (mg %)
DOSE LEVEL Mean - SD Mean - SD
Sham-operated 0 Cn=8 ) 6598 + 2039 42 + 47
500 Cn=4). 14579 + 6917 75 + 38
1 0 0 0 (n=3) 6995 + 4458 20 + 1 0
Goldblatt 0 (n=5) 8934 + 4490 81 + 81
500 Cn=3i 12320 + 3878 130 + 61
1 0 0 0 Cn=7i 1 0 8 8 8 + 8621 93 + 43
Doca-saline 0 Cn=81 11637 + 4923 336 + 676
500 Cn=4 ) 10038 + 4797 125 + 38
1 0 0 0 Cn=5i 9010 + 6278 94 + 65
Okomoto/Aoki 0 Cn=8 ) 9933 + 3752 41 + 44
500 Cn=41 12345 + 3234 68 + 38
1 0 0 0 Cn=51 10217 + 1756 64 + 45
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The histological findings differentiated the pathological changes 
into two distinct types, those due to hypertension and those due 
to treatment with aspirin.
The kidneys of the sham-operated control rats and of the Okomoto- 
Aoki control rats showed no significant pathological change. In 
the control Goldblatt rats, the clipped left kidney was small but 
the cortex and medulla appeared to be in proportion. The 
glomeruli had a normal appearance, and although the tubules were 
smaller in diameter than normal, they stained in a similar manner 
to the sham-operated controls. The blood vessels appeared normal. 
These atrophic changes are consistent with a diminished blood 
supply. In Goldblatt rats, the kidney is protected from effects 
of systemic hypertension by the silver clip. The changes encountered 
in the undipped kidney of the Goldblatt rat and in the single 
kidney of the Doca-saline rats were essentially similar. These 
kidneys were enlarged, with irregular cortical scarring and 
discolouration. The vascular changes mainly affected interlobular 
arteries and arterioles. Medial hypertrophy and duplication of the 
internal elastic laminae were present in most rats. The most 
severely affected animals showed focal necrotising arteritis (Fig.15). 
Some glomeruli appeared to be normal while the architecture of others 
was disrupted by fibrin thrombi within the capillaries, increased 
cellularity and obliteration of Bowman's space (Fig. 15). Later 
changes were characterised by loss of epithelial and endothelial - 
cells (Fig. 16) and eventually sclerotic hyalinised remnants 
were left. Focal or widespread tubular and interstitial 
changes were seen in these hypertensive rats. Tubular 
atrophy with collapse of the lumen was the most common change and 
interstitial fibrosis and mononuclear cell infiltration often 
accompanied this lesion (Fig. 16). However, groups of greatly 
distended colloid-filled tubules lined by a basophilic cuboidal 
epithelium were also seen.
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Fig. 15. A small artery showing fibrinoid necrosis 
(centre) and two glomeruli on either side showing 
fibrin thrombi, increased cellularity and occlusion of 
Bowman's space. An interstitial mononuclear cell infil­
tration is also seen (H&E x 200).
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Fig. 16. Two glomeruli show distended capillaries containing 
fibrin thrombi with few endothelial or epithelial cells. 
Interstitial fibrosis, mononuclear cell infiltration, atroohic 
collapsed cortical tubules and basophilic tubules lined by 
flattened cells are also present (H&E x 200).
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The lesions induced by aspirin, in these hypertensive rats, were 
similar to those previously encountered in the sexually modified 
male, mature female and a small number of male rats (Fig.17). The 
changes were mainly confined to the pars recta of the proximal 
convoluted tubules and affected less than five percent of the 
tubules in affected animals. In Goldblatt rats, both the left 
(clipped) and the right kidneys were affected.
The incidence of necrotic cortical tubules, together with the 
significant urinary changes are shown for each group in Table 41.
2.10.3 Discussion
The normotensive rats which developed necrotic changes because of 
aspirin, did not show blood pressure changes. Hypotension had been 
postulated as a cause of cortical tubular necrosis (Rosner, 1976), 
but this limited experimentation does not support this hypothesis. 
High blood pressure, and concommitant drug therapy are often present 
in human patients with analgesic nephropathy (Kincaid-Smith, 1978; 
Prescott, 1976). From this limited experimental work, there is no 
evidence to suggest that hypertensive rats are more susceptible to 
the nephrotoxic effects of aspirin.
2.11 Experiment 11
It is recorded that single doses of phenylbutazone from 50-400 mg/kg 
caused necrotic papillary changes in female Wistar rats (Arnold et al., 
1976). Similar necrotic changes were induced in rats given phenylbutazone 
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Fig. 17. Necrotic proximal convoluted tubules in an 
hypertensive rat (H&E x 470).
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This experiment was designed in order to elicit these nephrotoxic 
changes, comparing the effects in young 6-week-old rats and rats 
of 20 weeks of age. The dose level selected was 75 mg/kg/day, which 
is one-fifth of the LD50. The experiment was designed to last for 
ten days.
2.11.1 Materials and methods
The experimental design and methods were exactly the same as those 
described for aspirin in experiment 2 .
2.11.2 Results
No rats died during the treatment period. Administration of 
phenylbutazone did not affect body weight.
The amounts of food and water consumed are presented in Table 42.
The old male and female rats dosed with phenylbutazone consumed 
slightly more water than the controls.
The volume of urine voided after the first dose over a 24-hour 
period was slightly increased in the older rats (Table 43). The 
urinary enzyme activity showed wide-ranging values, although in the 
young male rats alkaline phosphatase was increased and in the older 
rats there was an increase in all enzymes measured (Table 44).
The results of the urinalysis performed after the final dose are shown
in Table 45. There is little evidence of any effect in any group.
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TABLE 42
Total amount of food and water consumed per group during ten day 
treatment period
Phenylbutazone YOUNG RATS




1514 1397 1150 1190
75 1498 1290 1505 1665
FOOD (grams)
905 665 970 785
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The absolute and relative kidney weights of control and treated rats 
are shown in Table 46. The kidney weights for the old animals are 
significantly increased, both in absolute and relative terms, above 
the control values. Macroscopic and microscopic examination of the 
kidneys revealed no treatment-related changes.
2.11.3 Discussion
The increase in water consumption accounts for the increase in the 
volume of urine voided in the first 24 hours when water was freely 
available. Kadokawa et al. (1979) gave phenylbutazone at dose 
levels of 3-30 mg/kg/day to Wistar rats for five days, and recorded 
decreased urine volume. The result of this study shows a consistent 
increase in the volume of urine voided.
Raab and Moerth (1973) found increased activity of alkaline phospha­
tase and LDH in the urine of rats given phenylbutazone at a dose 
level of 300 mg/kg but not at 150 mg/kg. From this study it can be 
concluded that 75 mg/kg phenylbutazone causes a marginal increase in 
enzymuria.
The increased kidney weight is difficult to interpret and it is 
probably an adaptive response. The absence of morphological 
change is a little surprising, because single doses of 50 mg/kg of 
phenylbutazone have been recorded as causing necrotic papillary 
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2.12 Experiment 12
The results of the previous experiments on aspirin, had shown that 
the strain of rat was of importance in the susceptibility to 
nephrotoxic damage. The following experiment was designed to 
investigate strain-related susceptibility to phenylbutazone.
2.12.1 Materials and methods
Groups of ten male and ten female rats, aged four weeks, of 
Sprague-Dawley, Lister Hooded and Wistar strain, were obtained from 
Olac Limited, together with ten male and ten female Fischer-344 
rats from Charles River, USA. The rats were maintained under 
standard conditions. Phenylbutazone at the dosage level of 200 
mg/kg/day was given to five male and five female rats of each strain, 
while five male and five female rats received the vehicle only and 
acted as controls. • The phenylbutazone was suspended in 1% methyl 
cellulose and given once daily by oral gavage at a dosage volume 
of 1 ml per 100 g bodyweight. The rats were six weeks old at the 
start of the experiment. Because of toxic signs, the dose level 
administered to the Wistar and Fischer-344 rats was lowered to 50 
mg/kg/day after three days of dosing.
The rats were examined prior to dosing and several times 
assessment of clinical or behavioural abnormalities. Body weight 
changes, food and water intake were monitored throughout the course 
of the study. Following the final dose on day 28, the rats were 
placed in metabolism cages and both food and water were withheld.
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Overnight 18-hour urine samples were examined for volume, specific 
gravity, pH, protein concentration, together with semi-quantitative 
determinations and microscopy of spun urine deposits. Following 
urine collection, the rats were bled and the blood samples were 
analysed for plasma urea and plasma creatinine. The rats were 
killed and examined microscopically, the kidneys were weighed, and 
samples of kidneys were processed for histological examination.
2.12.2 Results
Following three doses of phenylbutazone at the dosage level of 200 
mg/kg/day, two female Wistar rats were found dead. The cage mates 
showed hunched posture, piloerection and yellow staining of the 
fur. A male animal was in poor condition with marked swelling of 
the abdomen, this rat was killed and macroscopic post-mortem 
examination showed scattered focal ulcerations of the small intes­
tine with serous fluid within the peritoneal cavity. The Fischer- 
344 rats adopted a hunched posture and were lethargic. It was 
apparent that the dose of 200 mg/kg/day of phenylbutazone was having 
a serious gastro-intestinal effect, therefore the dosage was reduced 
for the Wistar and Fischer rats to 50 mg/kg/day.
On the fifth day a female Lister Hooded rat was found dead. 
Macroscopic examination did not reveal any cause of death. At 
histological examination the kidneys were within normal limits.
The growth curves for the four strains of rat are presented in 
Fig. 18. Although all male phenylbutazone-treated rats and the 
female Sprague-Dawley rats ate more food than the controls, the 
growth curves were not affected. The amount of food eaten and 
water drunk are presented in Fig.19 , and it is to be noted that all 
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Fig. 19. Food and water consumption by four strains of rat during 
28-day dosing period.
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The treatment produced only minor urinary changes. Lowered urinary 
pH was found in all except the male Fischer-344 rats. Increased 
amounts of protein were excreted in all the rats but male Fischer- 
344 and female Wistars (Table 47). The volume of urine voided 
and the specific gravity appeared to be unaffected by phenyl­
butazone. There were no significant increases in plasma urea or 
plasma creatinine in any strain investigated (Table 48).
The kidney weight data is presented in Table 49. With the 
exception of the male Fischer-344 rats the absolute and relative 
kidney weights of all rats were increased by treatment with 
phenylbutazone.
The histological appearance of the normal papilla is shown in Figure 
20. Phenylbutazone induced necrotic papillary changes which were 
morphologically similar in all the affected rats independent of strain. 
The capillaries, loops of Henle,interstitial tissues of the distal part 
of the papilla had disappeared and an amorphous material remained, 
which surrounded intact ànd apparently unaltered collecting ducts 
(Fig. 21). These changes extended up the central section of the 
papillae in some rats. The incidence of this finding is presented 
in Table 50.
2.12.3 Discussion
It had been suggested by Bokelman (1971) that two strains of rat 
treated with a non-steroidal anti-inflammatory drug showed 
different papillary lesions. This experiment shows that the 
papillary lesions induced by phenylbutazone appear similar 




Fig. 20. Section near the tip of the papilla of a control rat 
(H&E X  315).
:143:
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Fig. 21. Section near the tip of the papilla of a rat treated 
with phenylbutazone at 200 mg/kg/day for four weeks. The majority 
of collecting ducts appear intact, but the adjacent tissue is 
necrotic (H&E x 315).
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TABLE 47
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6.26 - 0.24 
5.9 - 0.11





6.28 - 0.13 
6.10 - 0.07 2 - 5
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TABLE 4 8
Plasma urea and creatinine in male and female rats receiving 
phenylbutazone (food and water withheld)
STRAIN* AND
DOSAGE
PLASMA UREA (mg %)
MALE FEMALE
Mean - SD Mean - SD








3 7 - 4  
30 - 4
4 2 - 6
4 8 - 9
0.74 - 0.09 0.64 - 0.06
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Cn=4I
5 0 - 5
4 9 - 2
Cn=31
0.62 - ,0.04 0.78 - 0.04
0.70 - O 
(n=4)





4 3 - 4  
41 - 6
0.66 - 0.15 0.70 - O
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Incidence of necrotic papillary changes in rats treated with 
phenylbutazone for 28 days
STRAIN OF RAT NUMBER NUMBER OF RATS WITH:
OF RATS No abnormality Necrotic changes















The Wistar and Fischer-344 rats were more susceptible to the toxic 
effects of phenylbutazone, necessitating reduction of dose level. 
There is no evidence to indicate different strain susceptibility 
to phenylbutazone-induced nephrotoxicity.
2.13- Experiment 13
The administration of phenylbutazone at 75 mg/kg/day for ten days 
did not produce histological changes in the kidneys of Sprague- 
Dawley rats. Nanra and Kincaid-Smith (1970) have reported that 
female Sprague-Dawley rats, subjected to 16 hours dehydration 
daily, and dosed with phenylbutazone at the level of 10 mg/kg/day 
for 8-20 weeks, developed renal papillary necrosis. Similar 
pathologies have been described in female Wistar rats by Arnold 
et al. (1976) when phenylbutazone was given at single doses of 50- 
400 mg/kg. Because phenylbutazone is often used as a reference 
standard compound in toxicological studies, its toxicity to the rat 
was investigated on daily administration of the compound for 13 
weeks.
2.13.1 Materials and methods
Twenty 4-week-old male Sprague-Dawley rats (CD strain) were divided 
into two groups, one group to receive the test compound and the other 
to act as controls. The rats were allowed to acclimatise for two 
weeks and were housed in suspended metal cages, five rats per cage, 
in rooms maintained at 21 - 2°C and 50 - 5% relative humidity. The 
lighting was controlled to give alternate periods of light (08.00- 
20.00 hrs) and dark. Spratts Laboratory Rodent Diet was fed ad
:151:
libitum and water was freely available. Phenylbutazone was given 
by oral gavage in 1% methyl cellulose at a dosage level of 200 
mg/kg/day. The control rats received 1% methylcellulose only.
The rats were dosed daily for 13 weeks at a constant dosage volume 
of 1 ml/100 g body weight. Fresh suspensions were prepared each 
day.
Clinical signs were recorded daily for each rat, the animals were 
weighed at weekly intervals, and the food consumed during the 
experimental period was recorded. During the first three weeks 
of study and during the final week the water consumption was 
measured daily, by weight. At weekly intervals, urine samples 
were collected from each rat over a period of 18 hours; during 
this period the animals were deprived of food and water. The 
urine samples were examined for volume, pH, specific gravity, 
protein concentration and osmolality. After 6 weeks of dosing 
blood pressure and heart rate were recorded at weekly intervals 
for all control and treated rats. The rats were placed 
individually in restrainers for a 30 minute period and the 
measurements were determined indirectly at the tail, using an 
animal blood pressure monitor (Huntingdon Instruments), with 
integral inflatable cuff and photoelectric pickup in the same 
unit. The blood pressure and heart rate were recorded on a 
standardised trace using a Devices M2 chart recorder with the 
trace running at 10 mm per second. After 13 weeks of dosing all 
the rats were anaesthetised and blood samples were taken from the 
orbital sinus; these were analysed for plasma urea and creatinine 
concentration. The rats were then killed by carbon dioxide 
asphyxiation and weighed. After macroscopic post mortem 
examination the kidneys of the rats were weighed and preserved in 
10% buffered neutral formalin. Sections were cut at 5 lyi, stained 
with haematoxylin and eosin, and examined under the light microscope
;152;
2.13.2 Results
No deaths were recorded during the experimental periods. On several 
occasions, following the dosing procedure, the rats receiving 
phenylbutazone salivated for a short period. The growth of the 
rats is depicted in Figure 22. Food consumption was not adversely 
affected and water consumption did not appear to be influenced by 
treatment with phenylbutazone.
The urinary volume and osmolality were not affected by treatment 
with phenylbutazone. The urinary specific gravity, pH, protein 
concentrations are shown in Figure 22. The specific gravity was 
raised (p>0.01) for weeks 4, 5, 6, 7, 10 and 13. The pH fell 
(p<0.001) from week 3-13 inclusive, and the protein concentration 
increased CpJ>0.01) from week 4-9 and week 11-13 inclusive in the 
rats receiving phenylbutazone at the dosage level of 200 mg/kg/day. 
The period of treatment with phenylbutazone had no effect on the 
blood pressure and heart rate of these rats when compared to the 
controls. Table 51 shows the results of the plasma urea and 
creatinine estimations. The urea concentration was slightly 
raised, but the serum creatinine concentration was similar in 
control and treated animals.
Macroscopic post mortem examination showed renal cortical scars 
in both control and treated animals, but only those rats receiving 
phenylbutazone showed enlargement of the kidneys. The kidney 
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Fig. 22 (a-d). Growth and urinary specific gravity, pH and protein 
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The histological examination showed a range of changes, in the 
distal portion of the papilla, attributable to the phenylbutazone 
administration. Total necrosis and focal mineralisation of the 
tips of the papilla were seen in one rat: this was the most marked 
lesion encountered (Figure 23) . Four rats showed bilateral patchy 
or diffuse necrotic changes, mineralisation and focal haemorrhage 
occurring beneath the intact pelvic epithelium and in the tissues 
surrounding the collecting ducts at the tip of the papillae. In one 
of these four rats there was hyperplasia of the epithelium lining 
the tip of the papillae and adjacent collecting ducts (Figure 24)
The other five rats did not show any of these changes. One of the 
four rats with sub total necrosis of the papilla showed, in the other 
kidney minimal dilation of the lumina of medullary and cortical 
tubules, without evidence of necrosis or degeneration. The minor 
cortical changes which were encountered in control and treated rats, 
were typical of spontaneous lesions seen in rats of this aae.
2.13.3 Discussion
The salivation following dosing was assumed to be caused by mechanical 
or chemical irritation. Body weight gain was reduced in rats 
receiving the test compound, because of impaired food utilisation.
The lowered urinary pH may reflect an altered acid-base balance. The 
increased urinary specific gravity may have been attributable to 
excretion of a metabolite. The increased but mild proteinuria is 
the most significant manifestation of phenylbutazone nephrotoxicity.
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Fig. 23. All elements of the tip of the paoilla are necrotic 
and mineralised debris is present (H&E x 200).
:157:
Fig. 24. Hyperplasia of the epithelium of the papillary tip and 
collecting ducts with adjacent necrotic tissue in a rat treated 
with phenylbutazone at 200 mg/kg/day for 13 weeks (H&E x 315).
:158;
The slightly raised serum urea levels in treated rats suggest minor 
renal damage. The kidney enlargement and recorded increase in 
weight are signs of nephrotoxicity. The histological findings 
are similar to those previously described with other non-steroidal 
anti-inflammatory drugs in the rat.
Five of the ten rats receiving phenylbutazone did not show any 
histologically detectable renal change after 13 weeks' dosing 
at a level of 200 mg/kg/day; this is in marked contrast to the 
renal papillary necrosis induced in female rats following single­
dose administration [Arnold et al., 1976). The results are, 
however, consistent with those recorded by Nanra and Kincaid-Smith 
(1970) when they used female Sprague-Dawley rats.
This experiment was carried out before the marked sex difference to 
nephrotoxicity in Sprague-Dawley rats had been appreciated. It is 
concluded that the male Sprague-Dawley rats are not particularly 
susceptible to the nephrotoxic effects of phenylbutazone, even 
when the compound is given at extremely high dosage levels.
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3. The effect of long-term dietary administration of indomethacin on 
the kidneys of rats
Indomethacin is an important non-steroidal anti-inflammatory drug which 
replaced phenylbutazone in the treatment of musculo skeletal pain 
because of the haematological toxicity of phenylbutazone. Gastro­
intestinal tract ulceration is the main complication of the 
administration of indomethacin but this drug is known to have 
effects on renal function also [Simon and Mills, 19.801. Indomethacin 
is often used as a reference standard compound in the toxicological 
assessment of new non-steroidal anti-inflammatory agents. Nanra and 
Kincaid-Smith (1973) have found that renal papillary necrosis can 
be induced in rats by indomethacin at the dosage level of 12 mg/kg/ 
day, given for a period of 12-30 weeks. There are no data on the 
prolonged administration of indomethacin to the rat.
3.1 Experiment 1
In this study, indomethacin was given to rats in their diet at the 
dosage level of 3.4 mg/kg/day for 52 weeks. We had intended to 
administer this dosage level for two years, but this proved impractical
3.1.1 Materials and methods
One hundred and thirty male and 130 female Sprague-Dawley rats [CD 
strain), aged 28 days, were maintained under standard conditions. 
Sixty-five male and 65 female rats received diet into which 
indomethacin BP had been incorporated, to give a calculated daily 
intake of 3.4 mg/kg/day. Sixty-five male and 65 female rats were fed 
a standard diet and acted as controls, fap water was freely available 
at all times.
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The rats were examined before dosing and several times daily during 
the treatment period, in order to assess clinical and behavioural 
abnormalities and for the early detection of moribund or dead 
animals. Body weight changes and food intake were monitored at 
weekly intervals throughout the study, and the water intake was 
recorded for five-day periods in weeks 6, 13 and 24,
After 6, 13, 26 and 52 weeks of treatment, blood samples were 
withdrawn from five male and five female animals from both treated 
and control groups, and the samples analysed for plasma urea and 
plasma creatinine concentrations. Blood samples were taken from 
the male rats after 26 and 52 weeks of withdrawal from the treatment, 
and urine samples for analysis were taken at the same time. Five 
male and five female animals from the control and treated groups 
were housed individually in urine analysis cages and urine samples 
were collected overnight. The volume of urine voided and specific 
gravity, pH and protein concentration were measured, together with 
semiquantitative determinations and microscopy of the spun deposits.
After 26 weeks of treatment, 15 treated males and 6 treated females, 
together with 15 control males and 14 control females, were killed. 
The remaining female rats were killed after 52 weeks. The surviving 
males, together with both control groups, were maintained for a 
further 52 weeks. Rats that were killed or died during the course 
of the study were subjected to detailed macroscopic examination, 
together with organ weight analysis. The kidneys were removed and 
prepared for histological examination.
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3.1.2 Results
A large number of rats, particularly female animals, died during 
the first year of the study, and it was decided to kill all the 
surviving female animals at this point. Although the death rate 
for the males was not as high dosing was stopped after 52 weeks and 
13 male rats were maintained to monitor recovery. The pattern of 
the mortalities and the determined kills is shown in Table 52.
A large number of deaths occurred after nine weeks of compound 
administration. The clinical signs shown by both male and female 
animals included a swollen abdomen, rapid loss of condition, 
emaciation and yellow smearing of the urogenital region. Animals 
were killed on humane grounds because of their moribund state. The 
post mortem examination of these rats showed marked intestinal 
ulceration, often with peritonitis. There was no real evidence that 
kidney changes were of great significance. The body weight gain of 
the male animals receiving indomethacin was similar to that of the 
controls, whereas in the female animals, from week 16 onwards there 
was a slight depression in body weight gain. There were no 
significant effects on food consumption or water intake.
Apart from a slight increase in plasma urea and creatinine in female 
rats at 13 weeks and in male rats at 24 weeks, no significant 
differences could be detected between the groups after one year of 
drug administration. The results are shown in Table 53.
Marginally higher volumes of dilute urine were excreted throughout 
the study by the male rats receiving indomethacin, but a less marked 
effect was seen in the female animals. A small increase in the pH 
was noted in males after 13 weeks of treatment. The results of the 
urine analysis are shown in Table 54.
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DURATION OF TREATMENT (weeks)
GROUP AND g 13 26 52 78 104
TREATMENT Mean - SD +Mean - SD +Mean - SD + +Hôsji “ SD Ms an — SD Mean - SD
URINARY
VOLUMES (mis)
Control cT 6.0 - 1.3 4.1 - 2.4 3.5 - 1.9 3.4 - 1.5 4.0 - 2.0 8.5 - 6.9
Indomethacin cf 8.0 — 2.4 9.1 ± 2.8** 5.5 - 1.9 8.0 — 1.6 6.1 - 1.9 15 - 7.2
Control 9 3.3 - 0.80 1.9 - 0.70 1.0 - 0.6 3.8 - 2.3 - -
Indomethacin 9 4.0 - 0.70 2.8 - 1.80 3.3 - 2.4 6.2 - 3.3 - -
URINARY SG
Control (f 1040- 3.6 1052 - 4.5 1055 Î 6.9 1054 - 7.8 1052 - 7.7 1040 - 11.6
Indomethacin 1039 i 2.9 1040- 3.1** 1047 - 2.2 1054 - 5.f* 1045 Î 2.9 1035' - 11.1
Control 9 1044 - 5.1 +1050 - 7.3 1052 i 6.1 1045-10.5 - -
Indomethacin 9 1042 - 4.5 1045- 5.4 1044 - 6.0 1039 - 8.8 - -
URINARY -pH
Control 0̂ 6.7 - 0.15 6.7 - 0.10 7.0 - 0.43 7.1 -, 0.23 7.0 - 0.20 7.1 - 0.81
Indomethac in 6.6 - 0.13 7.0 - 0.09* 7.0 - 0.30 7.1 Î 0.17 6.7 — 0.46 6.8 - 0.34
Control % 6.5 - 0.19 6.4 — 0.09 6.3 - 0.10 7.0 - 0.78 - -
Indomethac in ? 6.7 - 0.13 6.5 - 0.36 6.5 - 0.28 6.3 - 0.31* -
URINARY PROTEIN CONCENTRATION mg %
Control 26 - 20 42 - 11 32 - 23 78 - 43 396 - 467 366 - 343
Indomethacin (f 36 - 23 44 - 23 34 - 17 52 - 13 490 -443 340 - 55
Control ? 2 - 7 10 - 10 0 44 - 42 - -
Indomethac in ? 0 0 204 - 448 10 - 10 -
Level of significance * p<0.05 in comparison with controls
** p <0.01 in comparison with controls 
*** p cO.OOl in comparison with controls
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The kidney weights of animals killed at varying time intervals 
throughout the study are shown in Table 55. After 26 weeks of 
treatment the relative kidney weights for male and female animals 
were significantly increased above those of the controls and in 
the male animals the absolute kidney weights were also significantly 
increased. No comparative control data are available for female 
animals killed after 52 weeks of treatment, however, comparison 
with group mean values for rats maintained under similar conditions 
show no significant increase in kidney weights. In the male animals 
maintained without dosing from weeks 52 to 104, no significant kidney 
weight differences can be detected. The macroscopic appearance 
of the kidneys was normal. One male rat killed after 26 
weeks of treatment showed atypical bilateral uniform cortical 
scarring, and this animal was subsequently found to have severe 
renal damage with renal papillary fibrosis and secondary chronic 
interstitial nephritis. The results of the histological examination 
are presented in Table 55. Renal papillary necrosis was encountered 
only in indomethacin-treated rats. The first cases involved 
female rats from week 11 onwards. The necrotic tissue appeared . 
amorphous and eosinophilic with the H & E stain, and was stained 
more intensely with PAS reagent. Initially, the lesions were seen 
at the tip of the papilla and involved the interstitial tissue, 
loops of Henle, and capillaries. The collecting ducts and the 
overlying papillary epithelium were apparently unaffected.
In older rats, similar but more widespread areas of necrosis were 
seen (Fig. 25}. Later changes involved all the elements at the tip 
of the papilla and calcification of the necrotic tissue occurred. 
Cortical tubular changes were present and consisted of tubular 
dilatation, patches of interstitial fibrosis and lymphocyte 
infiltration. One female rat died during week 4 3 and a male rat 
killed during week 26 showed the most severe renal change. Effacement
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of the papilla occurred and small shrunken fibrotic remnants 
apparently lacking collecting ducts and lined by urothelial cells 
remained (Figs. 26 and 27). The cortex showed diffuse chronic 
interstitial nephritis (Fig. 28). Of the male rats maintained for a 
52-week recovery period, one animal showed severe renal damage; no 
other significant lesions were found.
3.1.3 Discussion
Indomethacin proved to be very toxic to rats because of the entero- 
hepatic recirculation of ulcerogenic compounds (Yesair et al.,
1970; Duggan et al.,1975 ; Shen, 1979). Female animals seem to be 
more susceptible to these toxic changes than are the males.
Both male and female rats developed some degree of renal change, but 
this was of great significance in only a few individuals. Although 
one interpretation of the results might be that the male rat is more 
susceptible to the nephrotoxic effects of indomethacin than the 
female, this is the case only because the female rats previously 
succumb to the gastrointestinal changes more readily than do the 
males.
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Fig. 25. Necrotic changes affecting the interstitium, loops of 
Henle and capillaries and largely sparing the collecting ducts 
(H&E X  200).
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Fig. 26. Fibrotic papillary remnant (arrow) and dilated renal 
tubules in a male rat treated with indomethacin at 3.4 mg/kg/day 





AM:% * ̂ .
Fig. 27. Papillary remnant lined hy epithelium as shown in Fig, 
26. Collecting ducts do not appear to penetrate the fibrous 




Fig. 28. Cortex of kidney shown in Fig. 26. Chronic interstitial 
nephritis (H&E x 315)..
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4. The laboratory rat as a model for renal toxicity
The value of animal models in drug safety evaluation is dependent 
on qualitative similarities between the animal model and man. The 
validity of the animal model can be affected by many extraneous 
factors. It must be accepted that simple extrapolation across 
species is unrealistic.
4.1. Factors affecting the validity of the rat model for 
nephrotoxicity
Laboratory strains of rats have originated from mutants of the brown 
rat, Rattus norvégiens. These laboratory strains represent homogen­
eous populations which have adapted well to a laboratory 
environment. Selective breeding has conferred many advantages, but 
some adverse effects have been introduced; the presence of chronic 
progressive nephropathy may be one such drawback. The pathogenesis 
of this condition is still not clear: the disease process is 
complex, influenced by environmental and heritable factors, and age- 
associated (Barthold, 1979). Male rats are more severely affected 
than females and strain differences are apparent. The Sprague- 
Dawley strain of rat seems to be more prone to chronic progressive 
nephropathy than the Wistar. A recent survey of renal lesions in 
wild rats showed no evidence of this condition (Gray et al., 1974). 
Other inherited renal conditions include cystic or absent kidneys 
in the ACI strain and renal papillary necrosis in the homozygous 
Gunn rat. Gunn rats are deficient in the enzyme uridine diphosphate 
glucuronyl transferase, which causes hyperbilirubinaemia and 
papillary necrosis because of the interstitial accumulation
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of bilirubin at that site. Spontaneously hypertensive rats also 
develop renal lesions and proteinuria as a result of sustained 
hypertension.
The laboratory rat is housed and maintained under unnatural 
conditions. Males and females are housed separately, so normal 
sexual activity cannot occur. The stressful social interactions 
in the caged animal may be a cause of kidney pathology (Barnett, 
1975) .
Laboratory rats are usually fed ^  libitum. Such a feeding regimen 
causes obesity, shortens longevity and increases the tumour profile. 
The protein content of the diet and the calcium and phosphorus ratio 
have important effects on the kidneys. Supplemented high-protein 
diets increase the weights of rat kidneys (MacKay and MacKay, 19 31; 
Whiting and Draper, 1981) . This effect has been attributed to the 
increased production of urea and acid. Clapp (19 80) reported that 
a diet with a low protein content of 12.9% caused an increase in 
the kidney weight, and this was attributed to the dietary amino 
acid composition. In this study Clapp (1980) also showed that an 
increased incidence of renal pelvic dilatation was correlated with 
the increased protein content of the diet. The source of dietary 
protein has been shown to affect the development of chronic 
progressive nephropathy in rats (Gray, 1977) . Some of the data 
presented are equivocal; however, additions of casein, beef muscle 
or liver to the diet have been shown to exacerbate chronic 
progressive nephropathy. If the ratio of dietary calcium to 
phosphorus becomes less than unity, nephrocalcinosis may occur 
(Clapp, 19 80). This condition has been shown to occur more commonly 
in females than in males and is exacerbated by oestrogens (Geary and 
Cousins, 1969); widespread parenchymal damage may occur if there is ■ 
heavy mineral deposition.
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The observation that renal change is sex-related in the rat has 
been mentioned several times in this thesis, and a female 
susceptibility to the nephrotoxic effect of aspirin has been 
demonstrated. It is known that female ?ex hormones affect the 
kidney. Oestradiol-receptor sites have been found in the kidney; 
these sites are similar to those found in the uterus and the 
vagina, but possibly have a greater affinity for oestrogens. 
Attachment of the hormone at these sites is believed to result in 
sodium retention (Devries et al., 1972). The enzyme which converts 
oestradiol to 16-keto-oestradiol is normally present in the kidneys 
of mature female rats only, but this enzyme can be induced in the 
kidneys of male or immature female rats by two weeks' administration 
of oestradiol (Ryan et al., 1963). Hydroxylation of oestradiol to 
catechol oestrogens, compounds which may have important neuro­
endocrine functions, has also been demonstrated in the rat kidney 
(Numazawa et al., 1980). It is difficult to speculate on the 
relevance of these sex-related factors in the development of 
spontaneous or drug-induced renal pathology.
It is apparent that the rat kidneys are affected by heritable, 
artificial environmental, dietary and hormonal' influences, which 
pose problems for the toxicologist who has to interpret changes in 
the kidneys.
4.2 The rat as~ an: experimental mod%i of nephrotoxicity
The kidneys of all mammals develop from the plates of embryonic 
mesenchyme known as the nephrotomes. The basic structure of the 
kidneys of the rat and man are similar in many aspects, notably
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shape and colour. They occupy similar retroperitoneal positions 
and relationships to the abdominal viscera, and are supplied with 
blood from the abdominal aorta. The weight of the kidneys, expressed 
as a percentage of body weight, is approximately 0.4 2% in the human 
and about 0.8% in the rat. This weight difference may be highly 
significant. On sectioning the rat kidney one finds a single long 
slender papilla, while in human kidneys numerous short papillae 
are to be found. The rat papilla projects into the large and highly 
folded pelvis, which extends into the outer medullary tissue: in 
the human kidney pelvis, major and minor calyces receive the 
papillae. In man the pelvis does not extend into the outer medullary 
tissue. The blood supply is via the renal artery which in man 
breaks up into several segmental arteries whereas, in the rat, 
because of the single papilla, the branching is less extensive. The 
fine blood vessels within the kidney substance are similar in both 
species, but the spiral arteries supplying the papilla have not been 
found in the rat (Moffat and Fourman, 1963) . The morphological 
structure of the nephrons is essentially similar in both rat and 
man. The pelvis of the rat appears to be lined by a permeable 
epithelium (Lacy, 1980). The human kidney pelvis is lined by 
transitional epithelium.
The kidney is an important regulator of homeostasis and the major 
excretory organ. The rat kidney has a greater ability to 
concentrate urine than that of man; this is related to the pelvic 
anatomy (Lacy, 1980). Urine excreted at the tip of the papilla can 
be refluxed into the fornical region of the pelvis and further 
concentrated in the rat. Prostaglandins are responsible for the 
modulation of renal blood flow: it has been demonstrated that renal 
prostaglandins in the rat may be different from those of other 
species (Gerber and Neis, 1979), and it is suggested that PGE may 
act as a vasoconstrictor in the rat rather than as a vasodilator.
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Male rats excrete globulin proteins in their urine (Alt, 1980a and b ) . 
These globulins are manufactured by the liver, are thought to have 
relevance in sexual function and have pheromonal properties. They are 
not found in the urine of castrate animals and have not been 
demonstrated in human urine.
The diagnosis of kidney damage can pose problems. Although 
sophisticated techniques have been developed for clinical use, these 
are not easy to use with animals with any degree of success. In 
toxicology, the approach must be simple and applicable to groups 
of animals and the techniques used should be readily repeatable. 
Because of these considerations the techniques that can be applied 
in safety evaluation studies are analysis of blood and urine 
samples, kidney weights and macroscopic and microscopic appearances 
of kidneys. The results presented here seem to validate this type 
of approach to nephrotoxicity. Blood urea concentration is not a 
reliable indicator of kidney function, and is increased only when 
considerable kidney damage has already taken place. Blood urea 
can be increased in a variety of morbid conditions, particularly 
in cardiovascular failure. Plasma or serum creatinine estimations 
seem to be more sensitive indicators of kidney, dysfunction.
Enzymuria is often recommended as the most sensitive non-invasive 
means of detecting nephrotoxicity before histological changes.
Enzyme release in the urine is affected by factors such as 
handling the animals, muscular activity and excitement; for mean­
ingful results it is, therefore, important for the animals to have 
long periods of acclimatisation in metabolism cages before samples 
are collected. This is impracticable in toxicological studies, and 
estimations of enzymes in urine are not routine procedures, 
although cytoplasmic or membrane-bound enzymes can be investigated.
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The latter were investigated in this study because it seemed 
probable that correlation could be established between the enzyme 
values and necrotic change. The results suggest that estimation 
of gamma-GT is useful in the assessment of kidney function in the 
rat. This enzyme is stable at room temperature and does not require 
dialysis ; collection of suitable urine samples does not, therefore, 
present difficulties. The highest concentration of gamma-GT is in 
the brush border of the epithelium of proximal tubules. Disruption 
of the cell membrane allows release of this enzyme into the urine, 
in which a certain amount of gamma-GT will always be found, because 
of cell turnover. A marked increase of this enzyme in the urine is 
associated with acute necrosis involving the convoluted and straight 
portions of the proximal tubules, but mainly the latter. Provided 
that the damage is not massive, regeneration of kidney tubules does 
occur, even with continued toxic insult. The replacement epithelium 
is usually tolerant to further insult. Experimental work has not 
yet been carried out to define the value of gamma-GT in the 
detection of chronic drug-induced renal damage. As the rate of 
urinary excretion is usually not known, the level of the enzyme is 
best expressed in terms of total activity in the volume of urine 
excreted.
The simple examinations performed on urine samples, including glucose 
determination, are sensitive enough to detect nephrotoxic damage, 
although age-related changes reduce the value of some of these 
determinations in old rats. When phenylbutazone was given to rats for 
13 weeks, an increased proteinuria and increased specific gravity 
were the most significant changes in the urine. In contrast, a human 
study on the effect of prolonged analgesic intake on the kidneys of 
women showed that lowered urinary specific gravity was the most 
significant urinary change. In this study a mixture of analgesics did 
not cause proteinuria (Dubach et al., 1978).
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Increasing the kidney weight of a rat by giving a chemical, is a 
common toxicological observation, but the mechanisms of these 
weight increases are often unknown. Of the factors that could 
increase kidney weight, cellular hypertrophy is the most common; 
this may represent a simple work hypertrophy, or the induction of 
drug-metabolizing enzymes. Basic degenerative changes can also 
increase kidney weight; these include water retention and cloudy, 
swelling or fatty change in the cortical tubules. An increase in 
epithelial cells in the cortical tubules can also increase kidney 
weight. Macroscopic examination of the kidney is not a sensitive 
method for detecting renal damage, and histopathological examination 
is necessary for identification of the sites of renal damage, whether 
medullary or cortical. Chronic progressive nephropathy is an 
important disease of rats because it affects longevity, destroys 
the renal parenchyma and affects renal function. The rat kidneys 
enlarge because of this condition, whereas in man the aging kidneys 
decrease in size and function because of the renal vascular damage. 
Renal tumours are rare in rats but conditions similar to renal 
neoplasms in man have been noted and the rat may be a useful model 
for man in this respect (Hard, 1976).
The acute cortical lesions produced in rats by a single dose of 
aspirin probably have a counterpart in man. It has long been known 
that celluria occurs in man after a single dose of aspirin. The 
necrotic and fibrotic papillary lesions and the secondary cortical 
changes found in rats are similar to those found in man.
The pharmacology and metabolism of the non-steroidal anti­
inflammatory drugs is complex. These drugs are bound to plasma 
protein and have a pKa value of about 4. This means that they may 
be concentrated in an acidic extracellular environment where they 
may inhibit prostaglandin synthetase. Because of these properties
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the kidneys, stomach and small intestine may be prone to injury by 
these drugs (Brune et al., 1976).
Some anti-inflammatory drugs are widely used to assess prostaglandin 
physiology. By inhibiting prostaglandin synthetase they affect 
renal haemodynamics and may cause short periods of hypertension 
in rats. It has recently been shown by Haylor and Lote (1980) 
that indomethacin causes sodium and water retention by directly 
inhibiting the effects of prostaglandins on renal tubules. The 
dosage of indomethacin required to stop renal prostaglandin synthesis 
in the rat is 10 mg/kg (Berl et al., 1977). Aspirin and indomethacin 
are reported to decrease renal blood flow and glomerular filtration 
rates in man (Kimberly et al., 1978); in premature infants, water, 
sodium, chloride and potassium excretion were reduced after 
indomethacin treatment (Cifuentes et al., 1979).
The half-life of aspirin is between 32 and 66 minutes in man. Most 
of the drug is hydrolysed to salicylate but some acetylsalicylate 
exists in plasma. The pharmacokinetics of salicylate in the rat 
are similar to those in man (Nelson et al., 1966), but biliary 
excretion does not occur in man but to a small 'degree in the rat 
(Hucker et al., 19 80). Salicylate and its metabolites are excreted 
almost entirely by the kidney and most rapidly when the urine is 
alkaline. Active secretion of salicylate occurs in the proximal 
tubule where necrotic changes are found in the rat and the final 
amount voided in the urine is dependent on the reabsorption in the 
remaining part of the nephron (Roch-Ramel et al., 1978). Less 
reabsorption occurs in alkaline urine.
In both rat and man, 60-70 percent of phenylbutazone is eliminated 
in the urine and 10-35 percent in the faeces. The plasma half-life 
of phenylbutazone is 6 hours in the rat and is 72 hours in man (Burns
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et al., 1953). The shorter half-life in the rat is related to 
biliary excretion which is approximately 16 times faster in the rat 
than in man. In the rat it is mainly the oxidised metabolites that 
are excreted in the urine, whereas in man the major urinary 
metabolites are conjugated with glucuronide.
Indomethacin has a plasma half-life of 4 hours in the rat and 2 
hours in man (Hucker et al., 1966). The drug is metabolised in 
similar ways in both species, but the metabolites are quantitatively 
very different. In the rat, most of the administered dose is 
excreted in the faeces. Indomethacin, like other non-steroidal 
anti-inflammatory agents, undergoes enterohepatic recirculation.
The conjugated metabolites excreted in the bile undergo cleavage and 
the free acid is re-absorbed through the intestinal mucosa. The 
prolonged exposure of the epithelium of the gut causes intestinal 
ulceration. This process has been quantified for indomethacin in 
the rat and man by Duggan et al. (1975). The minimum dose of 
indomethacin required to produce ulceration of the intestine of the 
rat was 0.75 mg/kg/day, whereas in man the estimatedvdose required 
was 10 mg/kg/day.
4.3 Extrapolation to man
Although the kidney is greatly involved in the elimination of 
foreign substances, surprisingly it is rarely damaged by potentially 
toxic compounds; it seems that these compounds make only a small 
contribution to the incidence of tubular damage and renal failure 
in man. The evidence which is cited for nephrotoxicity is 
epidemiological. The studies in animals are of doubtful relevance 
because of species differences and dose schedules.
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Extrapolation of animal data to man poses considerable problems, 
especially when metabolic differences occur. It has been shown 
by Heywood (19 81) that correlation of target-organ toxicity 
between rodent and non-rodent species is not high and, with 
respect to the kidney, is less than 20%. Fletcher (1978) in his 
survey of toxicological manifestations in experimental animals and 
adverse effects in man, showed that the kidney is a common target 
organ in animals, yet adverse effects on thé kidney in man are 
uncommon, and this he attributed to the low doses used in 
clinical treatment.
This work has shown that it is not easy to induce nephrotoxicity in 
rodents, particularly with compounds like aspirin, and it is 
often necessary to manipulate a number of variables to induce 
significant degrees of nephrotoxicity. Rosner (1976) reviewed 
experimental analgesic nephropathy and came to the conclusion 
that the toxicologist would never have expected, foreseen or 
predicted the existence of the- analgesic nephropathy syndrome, if 
clinicians had not highlighted the problem. The work carried out 
for this thesis confirms Rosner's view.
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Sprague-Dawley rats of the CD (Charles River Limited, Manston, Kent, 
U.K. or Wilmington, Mass, U.S.A.) and CFY (Anglia Laboratory 
Animals, Huntingdon, Cambridge) strains were used for the majority 
of these studies. All animals were allowed at least ten days 
acclimatisation to our laboratory environment before experimental 
treatment commenced.
(ii) Animal Management
Rats were housed in barrier-maintained rooms and caged in fives in 
suspended metal cages with wire-mesh flooring. Room temperature and 
relative humidity were maintained at 21 - 2° C and 5 0 - 5 %  
respectively. Lighting was controlled to give alternate 12 hour 
periods (8 am to 8 pm) of light and dark. Spratts Laboratory Rodent 
Diet No. 1 and tap water were freely available.
(iii) Body Weight Change, Food and Water Intake
The body weight of all animals was determined before the start of 
experimental treatment. Throughout the experiment body weight 
recordings were made at seven-day intervals. The cage mean water 
and food intake of rats was measured once weekly.
Civ) Withdrawal of Blood
The rats were bled by puncture of the orbital sinus under deep ether 
anaesthesia. The blood was collected in lithium heparin bottles (for 
plasma) or plain plastic vials (for serum)and allowed to stand at
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room temperature for at least 20 minutes. The rats were starved 
for a period of at least 16 hours prior to being bled.
(v) Routine Haematological Examination
Packed cell volume (PCV) - Estimated by Technicon 
Hemalog 8/90 Micro, using standard Technicon methodology
Red cell count CRBC) - Estimated by Technicon Hemalog 
8/90 Micro,using standard Technicon methodology
Haemoglobin (Hb) - Estimated by Technicon Hemalog 
8/90 Micro,using standard Techincon methodology
Absolute indices: Mean corpuscular haemoglobin
concentration (MCHC), mean cell volume (MOV) and mean 
corpuscular haemoglobin (MCH)
MCHC = Hb (g%) X 100 ♦ PCV (%)
MCV = PCV (%) X 10 4 RBC (mill/cmm)







Total white cell count (WBC) - Estimated by Technicon
Hemalog 8/90 Micro, using standard Technicon methodology lOOO/cmm
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(vi) Blood Chemistry
The estimations performed, together with the methods used were as 
follows:
Units
Serum urea nitrogen (BUN) - Technicon SMA 12/60, using mg/lOOml
standard Technicon SMA methodology (mg%)
Serum sodium (ma) - Technicon SMA 12/60, using standard 
Technicon SMA methodology mEq/1
Serum potassium (K) - Technicon SMA 12/60, using standard 
Technicon SMA methodology mEq/1
Serum Creatinine - Technicon SMA 12/60, using standard mg/100ml
Technicon SMA methodology (mg%)
(vii) Urinalysis
(i) pH - by pH meter
(ii) Specific gravity (SG) - by refractometer
(iii) ^-Glutamyl transpeptidase - Union carbide centrifichem,
Roche diagnostic test kit.
(iv) Protein - by precipitation with sulphosa-
licylic acid and quantitative 
estimation against Kingsway 
turbidimetric standards.
(v) Osmolality (Osmol) - Wescor Vapour Pressure
osmometer, mOsm/kg
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(vi) Reducing substances - Using Clinitest*
(vii) Glucose - Using Multistix*
(viii) Ketones - Using Multistix*
(ix) Bile pigments - Using Multistix*
(x) Urobilinogen - Using Multistix*
(xi) Haemoglobin - Using Multistix*
* Diagnositc reagent of Ames Company,
Stoke Poges, England.
For tests (vi) to (xi) inclusive, results were graded as 
follows:
0 - signifies negative
Tr - signifies marginal positive (trace)
+ - signifies positive
(xi) Microscopy of the spun deposit, after centrifugation at 
approximately 1500 'g' for 10 minutes, the deposit was 
examined for:








Gradings of cell frequency in deposits were 
recorded as follows:
0 - signifies none observed
1 - signifies few in some fields
2 - signifies few in all fields
3 - signifies many in all fields
(viii) Histological preparation
Representative samples of kidney were preserved for histopathological 
examination. The fixative used was formal saline. Following 
preservation and adequate fixation, the tissues were passed through 
graded ethanol solutions before being embedded in melted paraffin 
wax (56°C). Sections were cut at 5 pm. and stained with haematoxylin 
and eosin.
(ix) Statistical procedures
Measures of the distribution of the data were expressed as 
arithmetic means, standard deviations and absolute or 95% ranges. 
Tests of statistical probability included analysis of variance and 
paired 't ' test.
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